Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3036428	pf-ada	u/l (u/l)	2375	3010	0.17%
3036428	pf-ada	— (—)	261	295	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Heart failure, strict

790

1162

4.90

310.21

1.3

11.14

15.02

u/l

3.14

692

1105

Asthma, excluding more controls

323

40.35

308.55

1.3

1.1

13.27

9.11

u/l

1.35

284

Lung cancer and mesothelioma

569

89.31

307.65

1.3

1.1

13.63

8.86

u/l

0.69

555

All pneumoniae

1034

1120

6.25

307.65

1.3

16.01

12.54

u/l

2.27

936

1052

Suppurative and necrotic conditions of lower respiratory tract

303

146

23.90

307.65

1.4

1.2

26.33

12.54

u/l

5.53

287

134

Malignant neoplasm of bronchus and lung, including Hilmo

460

441

9.10

307.65

1.2

1.3

12.89

12.03

u/l

0.38

446

400

Malignant neoplasm of respiratory system and intrathoracic organs

543

431

11.03

307.65

1.3

14.65

11.83

u/l

1.10

530

392

Any death

788

1006

5.73

307.65

1.3

12.57

13.86

u/l

0.69

727

935

Heart failure,strict

720

852

6.10

307.65

1.4

1.2

11.34

15.38

u/l

3.10

635

819

Heart failure, not strict

820

1034

5.47

307.65

1.3

1.2

11.90

15.68

u/l

2.97

731

990

Pleural effusion

1505

164

117.30

307.65

1.4

1.1

14.25

13.47

u/l

0.16

1453

132

Asthma, unspecified (mode), excluding more controls

289

51.93

307.65

1.3

1.1

13.82

9.11

u/l

1.50

259

Pneumonias (Asthma/COPD co-morbidities)

1031

1124

6.24

307.65

1.3

16.07

12.50

u/l

2.39

933

1056

ILD differential diagnosis

514

113

22.99

307.65

1.3

1.1

12.28

8.06

u/l

1.32

478

Pneumonia, organism unspecified

985

1087

6.45

307.65

1.3

15.77

12.33

u/l

2.19

901

1024

Other pulmonary diagnosis

524

113

23.44

307.65

1.3

1.1

13.05

8.03

u/l

1.60

488

Excluding asthma or asthma-COPD overlap

515

113

23.03

307.65

1.3

1.1

12.32

8.03

u/l

1.35

479

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

923

927

6.11

307.65

1.3

16.15

12.37

u/l

2.28

844

869

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1028

1142

6.22

307.65

1.3

16.02

12.43

u/l

2.40

929

1074

923

927

6.11

307.65

1.3

16.15

12.37

u/l

2.28

844

869

COPD differential diagnosis

514

113

22.99

307.65

1.3

1.1

12.28

8.06

u/l

1.32

478

Other diseases of pleura

1869

457

38.94

307.65

1.4

1.1

14.02

14.69

u/l

0.17

1770

393

Other pleural conditions

775

102

92.05

307.65

1.4

1.1

13.42

14.87

u/l

0.20

732

Pyothorax

277

120

27.50

307.65

1.4

1.2

26.95

12.06

u/l

5.47

262

111

Asthma, unspecified (mode)

304

109

21.18

307.65

1.3

1.1

13.66

8.19

u/l

1.36

273

COPD (mode)

330

29.06

307.65

1.2

1.1

14.36

7.56

u/l

1.65

304

Other medical care

660

1074

5.65

307.65

1.3

12.24

14.05

u/l

1.15

618

1001

Influenza and pneumonia

1011

1095

5.94

307.65

1.3

16.13

12.46

u/l

2.46

918

1031

All-cause Heart Failure

767

1146

4.82

296.31

1.3

11.28

15.06

u/l

2.88

671

1089

Malignant neoplasm of bronchus and lung

398

382

9.01

289.74

1.2

1.3

12.59

11.46

u/l

0.48

389

345

Non-small cell lung cancer, including Hilmo

349

9.85

288.49

1.2

1.3

11.78

11.59

u/l

0.06

338

314

Later onset COPD, excluding more controls

243

25.29

287.16

1.3

1.1

14.26

8.40

u/l

1.00

222

Abnormal findings on diagnostic imaging of lung

677

1395

4.75

286.96

1.3

14.25

13.45

u/l

0.34

634

1286

Asthma (only as main-diagnosis), excluding more controls

275

37.65

281.22

1.3

1.1

13.47

9.11

u/l

1.43

242

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

763

1621

4.28

278.75

1.4

1.3

14.07

13.25

u/l

0.40

708

1491

Asthma

340

112

16.01

256.69

1.3

1.1

13.15

8.01

u/l

1.35

300

Dyspnoea

845

1638

3.86

253.46

1.4

1.2

13.28

14.21

u/l

0.45

778

1514

Bacterial infection, other or unspecified

667

1284

4.46

252.30

1.3

14.53

13.35

u/l

0.35

616

1198

Diseases of the respiratory system

362

135

13.54

246.93

1.3

1.1

11.68

9.11

u/l

0.83

336

114

Bacterial infection, other or unspecified

635

1267

4.42

239.44

1.3

14.50

13.34

u/l

0.33

586

1182

Asthma (only as main-diagnosis)

294

112

15.28

234.36

1.3

1.1

13.16

8.01

u/l

1.36

260

Other bacterial diseases

822

1484

3.76

231.02

1.3

14.91

13.66

u/l

0.44

742

1386

Asthma (mode)

307

113

14.63

227.20

1.3

1.1

11.77

8.06

u/l

1.06

275

Non-small cell lung cancer

245

234

10.92

223.09

1.2

1.3

11.61

11.52

u/l

0.02

237

209

Early onset COPD, excluding more controls

147

28.65

219.53

1.2

13.76

9.42

u/l

0.47

137

Other bacterial diseases

803

1413

3.64

211.41

1.3

15.67

13.49

u/l

0.90

733

1319

Oxycodone

498

955

4.81

210.56

1.3

12.23

14.30

u/l

1.44

467

876

Non-small cell lung cancer, adenocarcinoma

173

116

15.98

198.11

1.2

1.3

12.21

10.39

u/l

0.55

165

103

Heart failure and antihypertensive medication

322

267

8.06

192.51

1.4

1.3

11.11

17.14

u/l

2.29

279

250

Persons encountering health services for specific procedures and health care

781

1370

3.44

186.64

1.3

1.2

12.92

15.26

u/l

1.30

711

1274

Renal tubulo-interstitial diseases

715

1641

3.27

169.86

1.3

12.73

14.12

u/l

0.74

629

1544

Bacterial pneumonia, not elsewhere classified

395

722

4.89

169.51

1.3

15.45

12.08

u/l

1.32

331

686

Bacterial pneumoniae

402

750

4.79

168.67

1.3

15.50

12.07

u/l

1.39

337

712

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

770

1703

3.14

167.61

1.3

12.86

14.45

u/l

0.82

698

1584

Pneumothorax

120

24.02

167.21

1.3

1.1

13.24

14.96

u/l

0.15

113

Bacterial Sepsis

527

1218

3.75

159.34

1.3

12.91

13.68

u/l

0.26

462

1144

Non-ischemic cardiomyopathy

394

683

4.74

157.26

1.3

1.2

12.32

14.30

u/l

0.63

348

652

Abnormalities of breathing

639

1065

3.51

155.42

1.3

1.2

13.53

15.41

u/l

0.82

587

995

Renal failure

555

1422

3.51

153.18

1.3

10.38

14.40

u/l

4.63

478

1333

COPD/asthma/ILD related infections

651

927

3.54

151.20

1.3

14.12

12.37

u/l

1.01

595

869

COPD/asthma related infections

651

927

3.54

151.20

1.3

14.12

12.37

u/l

1.01

595

869

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

237

354

6.87

151.02

1.2

1.3

11.53

11.80

u/l

0.10

228

322

Implicit bacterial Sepsis

480

1149

3.76

147.13

1.4

1.3

12.79

13.64

u/l

0.27

416

1080

Implicit bacterial Sepsis

501

1202

3.65

146.22

1.4

1.3

12.86

13.67

u/l

0.26

435

1129

Heart failure and bmi 25plus

398

594

4.61

144.12

1.3

12.85

15.98

u/l

0.91

350

565

Non-small cell lung cancer, adenocarcinoma, helper endpoint

173

192

9.63

143.16

1.2

1.3

12.21

15.27

u/l

0.60

165

176

Pleural plaque

140

115

12.59

141.74

1.4

1.1

13.95

14.58

u/l

0.08

131

Implicit Sepsis

626

1506

3.16

141.45

1.3

13.04

14.30

u/l

0.46

551

1416

Malignant neoplasm

544

895

3.62

139.26

1.3

14.85

13.43

u/l

0.37

513

809

Non-invasive ventilation

219

287

6.91

134.97

1.4

1.2

11.58

16.36

u/l

2.07

171

281

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

263

489

5.42

131.59

1.2

1.3

11.53

12.09

u/l

0.27

247

447

Septicaemia

435

1126

3.66

130.64

1.3

13.72

13.34

u/l

0.10

385

1050

Malignant neoplasm, wide definition for exclusion

536

904

3.50

130.44

1.3

14.24

13.50

u/l

0.17

505

818

All chronic kidney diseases

521

1304

3.31

129.02

1.3

11.20

14.24

u/l

2.67

450

1231

Non-rheumatic valve diseases

394

700

4.11

127.92

1.4

1.2

11.77

16.13

u/l

1.97

355

672

All kidney diseases

677

1615

2.88

127.39

1.3

12.94

14.67

u/l

0.91

604

1523

Valvular heart disease excluding rheumatic fever

393

701

4.09

127.09

1.4

1.2

11.82

16.13

u/l

1.93

354

672

Other heart diseases, wide

512

899

3.50

126.79

1.3

1.2

13.18

16.43

u/l

1.08

459

857

Solid cancers, helper endpoint

520

889

3.48

125.70

1.3

14.97

13.47

u/l

0.38

489

804

Implicit Sepsis

619

1536

2.97

124.81

1.3

12.96

14.40

u/l

0.54

545

1443

Explicit Sepsis

439

1188

3.50

122.91

1.3

13.65

13.61

u/l

0.01

389

1116

Liquid cancers, helper endpoint

329

674

4.31

121.18

1.3

17.43

12.78

u/l

0.97

302

610

Dialysis, with operation codes

197

311

6.54

119.35

1.3

8.91

14.09

u/l

2.74

164

290

Nephropathy related operations

194

308

6.51

116.93

1.3

8.55

14.13

u/l

3.11

162

286

Any event in cancer register

539

1001

3.19

114.54

1.3

14.60

13.51

u/l

0.27

507

907

Other septicaemia

388

1052

3.60

114.31

1.3

13.44

13.40

u/l

0.01

342

980

Fever of other and unknown origin

454

1250

3.26

113.10

1.3

15.90

13.90

u/l

0.46

416

1172

Heart failure and coronary heart disease

502

1130

3.20

112.64

1.4

1.3

9.67

14.75

u/l

4.39

437

1057

Acute renal failure

288

670

4.40

112.58

1.3

10.16

15.10

u/l

3.18

249

624

First line medication for Crohn's disease

697

1380

2.75

111.78

1.3

1.2

15.06

14.00

u/l

0.34

641

1267

Other heart diseases

248

295

5.53

108.47

1.3

1.2

10.67

18.69

u/l

6.83

222

281

Chronic kidney disease

377

1081

3.48

105.87

1.3

10.19

14.49

u/l

3.43

319

1012

Oral corticosteroids

708

1646

2.57

103.05

1.3

1.2

14.08

13.54

u/l

0.26

646

1520

Condition for Implicit Sepsis (Organ dysfunction codes)

589

1525

2.74

102.38

1.3

13.10

14.47

u/l

0.48

519

1434

Any gastric operation

390

512

3.84

101.33

1.3

1.2

13.45

14.69

u/l

0.39

362

470

GASTRO-related operations

390

512

3.84

101.33

1.3

1.2

13.45

14.69

u/l

0.39

362

470

Atrial fibrillation and flutter

217

252

5.64

96.39

1.3

1.2

10.97

18.31

u/l

4.94

192

239

ILD medications: prednisolone, methylprednisolone, prednisone

687

1530

2.53

95.18

1.3

1.2

14.17

13.70

u/l

0.21

625

1415

Bacterial pneumonia (organism specified)

427

1296

3.02

93.89

1.3

15.53

13.05

u/l

0.94

361

1224

Condition for Implicit Sepsis (Organ dysfunction codes)

568

1477

2.67

93.08

1.3

13.06

14.65

u/l

0.58

506

1388

Atrial fibrillation and flutter with reimbursement

201

220

5.88

91.99

1.3

1.2

11.29

18.47

u/l

4.06

171

208

Erysipelas

501

1383

2.79

91.50

1.3

14.05

13.41

u/l

0.19

454

1293

Inflammatory bowel disease treatment related agents

703

1650

2.40

87.42

1.3

1.2

15.31

13.60

u/l

0.66

641

1523

ILD medications

681

1533

2.42

85.80

1.3

1.2

15.16

13.78

u/l

0.47

621

1418

Non-allergic asthma (mode)

15.50

80.23

1.3

1.2

12.27

9.56

u/l

0.23

Cardiomyopathy

172

347

5.04

80.06

1.3

1.2

10.63

16.35

u/l

1.35

153

333

Ascites

122

179

7.05

79.41

1.3

10.22

12.34

u/l

0.53

113

168

COPD

435

1305

2.76

79.04

1.3

14.88

13.48

u/l

0.43

403

1209

Care involving dialysis

111

149

7.68

78.18

1.4

1.2

7.50

11.63

u/l

3.24

137

Secondary uncertain malignant neoplasm

140

240

5.95

77.99

1.3

16.56

11.42

u/l

0.92

133

211

Aplastic and other anaemias

432

1514

2.69

77.20

1.3

13.43

13.35

u/l

0.02

383

1411

Other chronic obstructive pulmonary disease

417

1274

2.73

74.51

1.3

13.74

13.48

u/l

0.07

385

1183

Cardiac arrhythmias

285

528

3.53

73.17

1.3

1.2

11.24

18.08

u/l

3.72

251

502

Erysipelas

406

1338

2.71

72.91

1.3

13.73

13.54

u/l

0.04

364

1251

Other anaemias

402

1451

2.66

70.83

1.3

12.75

13.45

u/l

0.21

359

1349

Other and unspecified anaemias

398

1442

2.66

70.00

1.3

12.81

13.45

u/l

0.19

355

1340

Diseases of arteries, arterioles and capillaries (FINNGEN)

161

215

5.23

68.46

1.3

1.2

9.39

18.39

u/l

8.36

142

204

ILD medications: immunosuppressive drugs

364

1251

2.72

66.94

1.3

1.2

17.21

14.02

u/l

0.77

334

1154

COPD, early/later onset

423

1420

2.54

65.88

1.3

13.72

13.85

u/l

0.03

391

1314

Other chronic obstructive pulmonary disease, including avohilmo

459

1569

2.44

65.62

1.3

13.65

13.75

u/l

0.03

423

1446

COPD, hospital admissions

420

1414

2.54

65.49

1.3

13.87

13.83

u/l

0.01

388

1309

Covid-19 confirmed case

316

1116

2.86

64.77

1.3

16.80

13.00

u/l

0.73

291

1025

Haemorrhage from respiratory passages

281

846

3.02

62.16

1.3

1.2

11.91

14.24

u/l

1.15

253

796

COPD related to multimorbidity

384

1285

2.55

60.60

1.3

13.78

13.92

u/l

0.03

354

1188

Cerebrovascular diseases (FINNGEN)

162

252

4.58

60.20

1.3

1.2

11.56

18.44

u/l

3.48

147

240

Other disorders of fluid, electrolyte and acid-base balance

281

919

2.95

60.03

1.2

1.3

11.41

13.48

u/l

0.59

253

848

Continuous positive airway pressure

143

255

4.78

59.35

1.2

1.3

15.07

16.70

u/l

0.27

134

248

Certain infectious and parasitic diseases

504

1073

2.36

59.16

1.3

13.11

13.44

u/l

0.12

460

1017

Implicit viral Sepsis

241

774

3.15

58.51

1.4

1.3

12.74

13.84

u/l

0.24

216

723

Codes for special purposes

362

1442

2.52

58.20

1.3

17.18

13.15

u/l

0.94

333

1331

Provisional assignment of new diseases of uncertain etiology

361

1439

2.52

57.96

1.3

17.20

13.16

u/l

0.94

332

1328

COPD, hospital admission 2, with asthma infections

328

1056

2.70

57.91

1.2

1.3

13.93

13.89

u/l

0.01

300

974

Infections, IBD-co-morbidities

141

205

4.97

57.50

1.4

1.2

18.50

13.06

u/l

1.63

126

196

Extracorporeal dialysis

142

6.70

57.19

1.4

1.2

7.35

12.50

u/l

2.49

131

Non-Hodgkin lymphoma, all, including Hilmo

121

243

5.07

56.78

1.3

28.53

11.98

u/l

1.60

112

215

All influenza

165

424

3.93

56.42

1.4

1.3

16.01

12.19

u/l

0.67

149

403

COPD, hospital admissions 3, with asthma pneumonia sepsis

299

928

2.79

56.28

1.2

1.3

14.06

13.62

u/l

0.10

271

852

Asthma-related pneumonia

309

1159

2.69

56.28

1.2

1.3

14.01

13.41

u/l

0.14

268

1072

Asthma, hospital admissions 3, pneumonia

309

1160

2.69

56.17

1.2

1.3

14.01

13.40

u/l

0.14

268

1073

Asthma-related pneumonia or sepsis

309

1160

2.69

56.17

1.2

1.3

14.01

13.40

u/l

0.14

268

1073

Implicit viral Sepsis

182

507

3.64

55.53

1.3

13.12

13.04

u/l

0.01

164

473

Viral Sepsis

182

507

3.64

55.53

1.3

13.12

13.04

u/l

0.01

164

473

ILD, hospital admissions 3, with pneumonia sepsis

102

180

5.80

55.31

1.3

15.89

12.16

u/l

0.79

170

Other arrhythmias

305

838

2.76

55.04

1.3

1.2

14.21

16.13

u/l

0.60

275

800

Pulmonary heart disease, diseases of pulmonary circulation

288

1058

2.75

54.91

1.3

10.71

14.47

u/l

3.63

265

973

Cardiomyopathy (excluding other)

118

243

4.94

53.79

1.2

11.50

16.88

u/l

0.72

104

228

Opioids

489

1123

2.27

53.30

1.3

11.89

15.53

u/l

2.87

453

1032

ILD, hospital admission 2, with pulmonary infections

106

201

5.38

53.15

1.3

16.08

11.76

u/l

1.07

192

Conduction disorders

212

525

3.30

52.92

1.4

1.2

11.37

15.82

u/l

1.53

188

507

Viral pneumonia

104

197

5.35

52.12

1.4

1.3

10.81

12.03

u/l

0.37

188

Transplanted organ and tissue status

180

5.61

51.95

1.3

7.72

13.57

u/l

4.15

168

L04AD Calcineurin inhibitors

171

5.71

51.47

1.3

9.38

11.48

u/l

1.20

161

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

122

268

4.62

51.43

1.3

17.76

11.61

u/l

1.00

115

240

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

528

1636

2.11

51.29

1.3

13.85

14.40

u/l

0.11

475

1532

Tramadol

419

1105

2.34

51.28

1.3

12.15

15.20

u/l

2.01

387

1015

Polyarthropathies

442

1282

2.26

50.97

1.3

16.38

13.59

u/l

0.76

402

1191

Bleeding

529

1816

2.08

50.65

1.3

12.38

14.33

u/l

0.83

476

1685

Valvular operations

126

288

4.44

50.54

1.4

1.2

12.73

16.92

u/l

0.66

121

273

AV-block

158

365

3.84

50.33

1.4

1.2

11.76

15.90

u/l

0.90

139

349

Cardiomyopathies, Primary/intrinsic

112

236

4.82

49.71

1.2

11.68

16.53

u/l

0.59

222

Cardiovascular diseases (excluding rheumatic etc)

194

310

3.61

49.56

1.2

11.53

19.00

u/l

7.08

179

296

Pulmonary embolism

253

934

2.74

47.87

1.3

11.19

14.56

u/l

2.56

232

857

Hypertensive heart and/or renal disease

236

605

2.94

47.52

1.3

10.46

15.21

u/l

2.58

212

578

Malaise and fatigue

340

1144

2.41

47.33

1.3

14.62

13.63

u/l

0.31

305

1073

Pulmonary heart disease

253

945

2.71

46.80

1.3

11.19

14.43

u/l

2.43

232

867

Neoplasms

297

583

2.71

46.79

1.3

13.46

15.34

u/l

0.73

277

527

Acute tubulo-interstitial nephritis

378

1448

2.27

46.55

1.3

15.09

13.98

u/l

0.32

342

1365

Presence of cardiac and vascular implants and grafts

384

1261

2.28

46.44

1.4

1.3

9.84

14.13

u/l

3.13

338

1183

Glomerular disorders in diseases classified elsewhere

128

318

4.11

46.17

1.3

11.22

13.63

u/l

0.52

110

295

Primary_lymphoid and hematopoietic malignant neoplasms

219

765

2.90

46.09

1.3

20.85

13.50

u/l

1.11

202

695

Codeine

448

1114

2.19

45.78

1.3

13.68

15.46

u/l

0.60

409

1025

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

166

284

3.71

45.53

1.3

1.2

20.38

17.81

u/l

0.19

143

271

Diseases of arteries, arterioles and capillaries

479

1733

2.05

44.63

1.3

11.09

13.97

u/l

1.91

425

1615

Other respiratory disorders and diseases

204

698

2.96

44.62

1.5

1.3

13.69

13.21

u/l

0.08

182

635

Other diseases of the respiratory system

204

698

2.96

44.62

1.5

1.3

13.69

13.21

u/l

0.08

182

635

Any reimbursement code in KELA

168

218

3.87

44.59

1.3

1.2

11.89

19.10

u/l

4.40

155

201

Other CVD (FINNGEN)

131

5.58

44.31

1.3

1.2

15.55

15.89

u/l

0.02

124

Glomerular diseases

167

515

3.29

43.64

1.3

11.94

12.92

u/l

0.23

142

478

Venous thromboembolism

388

1751

2.16

43.18

1.3

11.88

13.65

u/l

1.48

349

1620

DVT of lower extremities and pulmonary embolism

325

1412

2.31

43.07

1.3

11.63

13.76

u/l

1.69

295

1302

Complications of surgical and medical care, not elsewhere classified

556

1980

1.93

43.00

1.3

13.11

14.08

u/l

0.34

508

1832

Metabolic disorders

512

1565

2.00

42.86

1.3

12.97

14.40

u/l

0.59

465

1449

Symptoms and signs involving the circulatory and respiratory systems

451

1066

2.13

41.86

1.3

1.2

11.64

15.42

u/l

3.28

411

996

Chronic lower respiratory diseases

614

1747

1.88

41.25

1.3

14.44

14.13

u/l

0.08

556

1619

Paroxysmal tachycardia

109

213

4.31

40.19

1.3

1.2

8.35

17.82

u/l

10.49

205

General symptoms and signs

521

1331

1.97

39.48

1.3

12.87

14.10

u/l

0.65

475

1249

Hypertensive diseases (excluding secondary)

167

296

3.29

37.60

1.2

11.61

18.52

u/l

5.90

152

282

Malignant neoplasm of breast, HER2-negative, including Hilmo

153

294

3.39

37.32

1.2

11.49

12.02

u/l

0.13

140

254

Malignant neoplasm of breast, including Hilmo

153

294

3.38

37.31

1.2

11.49

12.02

u/l

0.13

140

254

Iron deficiency anaemia

299

1323

2.24

36.98

1.3

13.89

13.53

u/l

0.06

262

1227

Non-small cell lung cancer, squamous

100

6.36

36.95

1.2

9.52

11.00

u/l

0.51

Malignant neoplasm of skin

262

737

2.45

36.64

1.2

1.3

14.57

12.62

u/l

0.56

243

665

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

258

715

2.46

36.34

1.2

1.3

17.59

12.58

u/l

0.86

239

643

Diabetic nephropathy, excluding more controls

135

330

3.42

35.65

1.3

10.82

13.68

u/l

0.81

116

310

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

108

187

4.15

35.62

1.3

1.2

14.63

12.80

u/l

0.34

179

Later onset COPD

282

985

2.31

35.55

1.3

13.75

13.71

u/l

0.01

260

899

Gout

257

963

2.37

35.34

1.3

14.03

14.13

u/l

0.01

229

895

Malignant neoplasm of breast, HER2-negative

148

294

3.31

35.04

1.2

11.59

12.02

u/l

0.10

138

254

Asthma-related infections

343

1627

2.07

34.90

1.2

1.3

13.93

13.86

u/l

0.02

302

1509

Asthma, hospital admission 2, infections

343

1627

2.07

34.90

1.2

1.3

13.93

13.86

u/l

0.02

302

1509

Malignant neoplasm of breast

148

294

3.30

34.84

1.2

11.55

12.02

u/l

0.11

138

254

Other diseases of blood and blood-forming organs, wide

166

583

2.88

34.71

1.3

14.65

12.49

u/l

0.35

157

537

Pain in throat and chest

368

1062

2.09

34.41

1.3

1.2

13.94

15.31

u/l

0.36

334

992

Autoimmune diseases excluding thyroid diseases, strict definition

530

1582

1.84

33.90

1.3

16.97

13.55

u/l

1.20

478

1471

Pacemaker

291

1286

2.19

33.70

1.4

1.3

10.02

13.58

u/l

1.64

256

1186

Hypertensive Heart Disease

196

582

2.66

33.49

1.3

11.20

14.97

u/l

1.51

178

557

Basal cell carcinoma, including avohilmo

242

689

2.43

33.47

1.3

16.16

12.57

u/l

1.09

226

624

Hypo-osmolality and hyponatraemia

148

495

3.01

33.45

1.2

1.3

10.44

12.33

u/l

0.84

132

452

Complications of procedures, not elsewhere classified

442

1945

1.89

33.39

1.3

13.71

14.07

u/l

0.09

405

1800

Autoimmune diseases excluding thyroid diseases

543

1635

1.82

33.38

1.3

16.92

13.49

u/l

1.24

487

1519

Caries of dentine

165

575

2.82

33.04

1.3

17.73

13.86

u/l

0.53

154

532

Cardiovascular diseases

154

259

3.20

32.51

1.2

11.51

20.33

u/l

7.04

145

247

Other malignant neoplasms of skin (=non-melanoma skin cancer)

240

690

2.40

32.15

1.3

16.17

12.58

u/l

1.07

223

624

Basal cell carcinoma

236

684

2.40

31.79

1.2

1.3

16.20

12.58

u/l

1.07

221

618

Diseases of oesophagus, stomach and duodenum

543

1833

1.78

31.71

1.3

13.20

14.43

u/l

0.43

491

1703

Complications of medical and surgical care

410

2003

1.89

31.68

1.3

12.31

13.79

u/l

0.57

371

1855

Gout, FINNGEN

257

1159

2.23

31.53

1.3

14.03

14.41

u/l

0.04

229

1070

Parasetamol

338

811

2.12

31.38

1.3

14.81

13.63

u/l

0.33

312

754

Dental caries

175

639

2.65

31.23

1.3

17.54

13.95

u/l

0.53

164

583

Certain infectious and parasitic diseases

354

859

2.07

30.94

1.3

12.87

13.36

u/l

0.14

327

808

Other and unspecified iron deficiency

229

994

2.32

30.88

1.3

14.75

13.37

u/l

0.20

205

915

Serous carcinoma of ovary, including Hilmo

10.91

30.53

1.2

9.97

9.04

u/l

0.26

Adjustment and management of implanted device

151

541

2.82

30.51

1.3

9.22

14.14

u/l

3.19

141

498

Nutritional anaemias

329

1593

2.00

30.34

1.3

13.41

13.37

u/l

0.01

288

1479

Type 2 diabetes, wide definition

445

1544

1.85

30.15

1.3

11.22

14.66

u/l

3.82

405

1440

L04AA Selective immunosuppressants

133

450

2.98

29.79

1.3

15.41

12.17

u/l

1.02

123

414

Enterocolitis due to Clostridium difficile

103

300

3.49

29.66

1.4

1.3

12.03

12.87

u/l

0.13

276

Pleural plaque with presence of asbestos

110

337

3.36

29.44

1.3

14.59

13.05

u/l

0.30

104

312

Hypertension, essential

334

927

2.05

29.30

1.3

1.2

13.71

16.12

u/l

0.74

302

877

COPD-related respiratory insufficiency

125

415

3.06

29.10

1.3

11.89

13.12

u/l

0.22

110

378

Unspecified kidney failure

102

303

3.42

28.52

1.3

8.69

14.07

u/l

2.62

277

Peripheral artery disease

341

1398

1.96

28.37

1.3

9.76

14.35

u/l

5.26

297

1302

Care involving use of rehabilitation procedures

286

1295

2.04

27.65

1.3

1.2

14.20

14.90

u/l

0.13

237

1203

STROKE

281

915

2.10

27.50

1.3

12.28

15.28

u/l

1.10

246

860

Secondary hypertension

5.81

27.40

1.2

11.33

15.68

u/l

1.25

Other bacterial intestinal infections

136

490

2.80

27.24

1.4

1.3

12.71

11.98

u/l

0.16

119

453

Percutaneous Coronary Intervention

412

1378

1.84

27.15

1.3

12.53

15.24

u/l

1.10

371

1286

Cardiodefibrillation

275

1351

2.05

27.12

1.3

9.72

14.74

u/l

7.10

257

1245

Other respiratory diseases principally affecting the interstitium

161

636

2.56

26.93

1.3

14.54

13.14

u/l

0.34

142

577

Other acute lower respiratory infections

308

1503

1.96

26.88

1.3

16.01

13.64

u/l

0.44

285

1386

Insulin medication

353

1585

1.88

26.61

1.4

1.3

11.43

14.59

u/l

2.36

311

1474

Explicit bacterial Sepsis

260

3.51

26.27

1.1

1.3

16.73

11.48

u/l

0.51

244

Malignant neoplasm of digestive organs

199

676

2.34

26.17

1.3

14.23

12.63

u/l

0.33

175

611

Calcific aortic valvular stenosis

257

1212

2.08

26.12

1.4

1.3

13.53

13.10

u/l

0.07

232

1113

Calcific aortic valvular stenosis, operated

257

1212

2.08

26.12

1.4

1.3

13.53

13.10

u/l

0.07

232

1113

Calcific aortic valvular stenosis, diagnosis (helper)

257

1212

2.08

26.11

1.4

1.3

13.53

13.10

u/l

0.07

232

1113

Operations 2 for CAVS

257

1212

2.08

26.11

1.4

1.3

13.53

13.10

u/l

0.07

232

1113

Other disorders of skin and subcutaneous tissue

393

1946

1.80

26.06

1.3

13.80

13.75

u/l

0.01

350

1804

Calcific aortic valvular stenosis, including rheumatic fever

257

1216

2.07

25.82

1.4

1.3

13.53

13.09

u/l

0.07

232

1117

Coronary revascularization (ANGIO or CABG)

407

1378

1.82

25.73

1.3

12.39

15.24

u/l

1.18

367

1286

Intestinal infectious diseases

463

2047

1.72

25.58

1.3

13.89

14.09

u/l

0.06

409

1907

Emergency coronary revascularization (for ACS)

460

1607

1.75

25.55

1.3

12.32

14.74

u/l

1.09

414

1498

Implicit fungal Sepsis

148

4.40

25.54

1.5

1.2

10.49

12.04

u/l

0.40

140

Fibrosis and cirrhosis of liver

200

3.87

25.52

1.4

1.3

10.27

12.20

u/l

0.69

181

Gout, idiopatic and unspecified

213

975

2.21

25.52

1.3

10.35

14.45

u/l

2.42

191

899

Cough

196

815

2.29

25.50

1.3

1.2

12.21

14.27

u/l

1.12

173

766

Hard cardiovascular diseases

403

1329

1.81

25.32

1.3

12.54

15.57

u/l

1.31

363

1241

Hernia of abdominal wall, postoperative

242

3.54

25.31

1.2

15.20

15.02

u/l

0.02

220

Hyperkalaemia

158

4.27

25.23

1.3

1.2

7.77

12.76

u/l

3.66

143

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

194

3.86

24.93

1.2

16.21

12.05

u/l

0.55

172

Disorders of lipoprotein metabolism and other lipidaemias

432

1524

1.76

24.84

1.3

14.36

14.32

u/l

0.01

396

1411

Hypertensive diseases

320

928

1.95

24.79

1.3

1.2

12.12

16.11

u/l

2.42

290

878

Hypertension

319

928

1.95

24.49

1.3

1.2

12.14

16.11

u/l

2.40

289

878

Bacterial intestinal infections, IBD co-morbidities

134

507

2.67

24.47

1.4

1.3

12.64

12.63

u/l

0.00

118

465

Malignant neoplasm of breast, ER-positive, including Hilmo

110

279

3.05

24.27

1.2

12.01

11.93

u/l

0.02

101

241

Other bacterial intestinal infections

150

602

2.51

24.26

1.3

12.58

12.05

u/l

0.12

130

555

Streptococcal septicaemia

223

3.60

23.95

1.1

1.3

17.96

14.47

u/l

0.25

204

Malignant neoplasm of breast, HER-positive

108

278

3.04

23.76

1.2

12.06

11.94

u/l

0.02

240

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

124

459

2.74

23.70

1.4

1.3

15.62

13.27

u/l

0.25

113

425

Malignant neoplasm of urinary organs

188

3.83

23.61

1.2

1.3

16.50

10.44

u/l

0.87

166

COPD, hospital admissions 1, only main diagnosis

273

1196

1.97

23.59

1.2

1.3

13.72

13.79

u/l

0.01

254

1100

Atherosclerosis, excluding cerebral and coronary sclerosis

318

1350

1.88

23.55

1.3

9.89

14.19

u/l

4.49

278

1257

Codeine or tramadol medication

546

1829

1.64

23.49

1.2

1.3

13.53

14.24

u/l

0.27

499

1695

Enlarged lymph nodes

102

342

3.01

23.33

1.4

1.3

13.52

12.84

u/l

0.15

318

Ulcer of lower limb, not elsewhere classified

124

466

2.69

23.02

1.3

10.15

12.69

u/l

1.14

114

424

543

1723

1.63

22.79

1.3

13.98

13.51

u/l

0.18

500

1604

Ischemic heart diseases

404

1389

1.75

22.74

1.3

12.08

15.20

u/l

1.45

362

1295

Diabetic nephropathy

137

537

2.55

22.71

1.3

10.72

13.24

u/l

0.68

118

496

Pure hypercholesterolaemia

398

1494

1.75

22.47

1.3

14.20

14.38

u/l

0.06

366

1382

Bronchitis

518

2010

1.63

22.44

1.3

13.39

13.86

u/l

0.22

479

1854

Volume depletion

274

3.22

22.23

1.2

9.29

12.56

u/l

1.81

247

Oedema, not elsewhere classified

190

866

2.18

22.18

1.4

1.3

10.83

13.73

u/l

1.40

169

808

Cardiomyopathy, other and unspecified

135

4.28

22.07

1.6

1.2

15.63

14.77

u/l

0.04

129

Major coronary heart disease event

425

1506

1.71

21.95

1.3

11.71

15.06

u/l

1.76

380

1407

Nonischemic cardiomyopathy

266

3.24

21.91

1.2

1.3

15.32

13.22

u/l

0.15

247

Diarrhoea and gastroenteritis of presumed infectious origin

339

1724

1.78

21.66

1.3

14.17

14.31

u/l

0.03

301

1608

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

331

1843

1.78

21.56

1.3

12.15

13.72

u/l

0.54

302

1706

L04AX Other immunosuppressants

264

1390

1.91

21.49

1.3

19.36

13.59

u/l

1.26

246

1283

Asthma/COPD (KELA code 203)

427

1745

1.68

21.41

1.3

13.76

14.13

u/l

0.09

387

1618

Diseases of the digestive system

290

1573

1.84

21.23

1.3

12.68

13.69

u/l

0.20

259

1457

Second line medication for Crohn's disease

267

1418

1.89

21.18

1.3

19.31

13.59

u/l

1.27

249

1308

Gout, strict definition

160

705

2.30

21.15

1.4

1.3

9.30

14.42

u/l

2.60

142

647

GI-bleeding

234

1192

1.98

21.11

1.3

13.11

13.81

u/l

0.10

208

1105

Diseases of liver

199

957

2.09

21.04

1.3

14.40

13.97

u/l

0.06

179

882

Kidney transplant status

5.15

20.75

1.3

1.2

7.06

11.29

u/l

3.00

Malignant neoplasm of kidney, except renal pelvis

173

3.75

20.71

1.2

17.26

10.65

u/l

0.88

153

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

118

206

2.88

20.70

1.2

12.71

15.66

u/l

0.70

106

195

Other diseases of the digestive system

232

1187

1.97

20.68

1.3

13.14

13.86

u/l

0.10

206

1101

Gout, unspecified

172

791

2.20

20.50

1.3

10.44

14.75

u/l

1.91

154

728

ILD, hospital admissions

131

538

2.46

20.33

1.3

14.90

13.22

u/l

0.36

119

493

Insulin, fast-acting

207

1024

2.03

20.25

1.4

1.3

11.07

14.38

u/l

1.67

180

943

Insulin, combination of fast acting with intermediate-acting or long-acting

353

1883

1.72

20.19

1.4

1.3

11.43

14.44

u/l

2.40

311

1752

Other interstitial pulmonary diseases

132

546

2.45

20.17

1.3

15.18

13.17

u/l

0.45

120

499

Non-follicular lymphoma

291

3.04

20.14

1.3

31.12

11.93

u/l

1.29

266

Amputation

340

2.86

20.03

1.3

9.44

14.37

u/l

2.00

313

Iron deficiency anaemia secondary to blood loss (chronic)

114

442

2.60

19.93

1.3

13.98

12.25

u/l

0.19

410

Reimbursement for rheumatic diseases

277

1512

1.83

19.93

1.3

15.93

13.44

u/l

1.46

259

1389

Interstitial lung disease

132

550

2.43

19.86

1.3

15.18

13.13

u/l

0.46

120

503

Interstitial lung disease endpoints

132

550

2.43

19.86

1.3

15.18

13.13

u/l

0.46

120

503

Early onset COPD

147

644

2.30

19.68

1.2

1.3

13.76

12.87

u/l

0.19

137

597

Disorders of lens

362

1314

1.73

19.58

1.3

11.37

14.01

u/l

2.15

323

1224

Dipeptidyl peptidase 4 (DPP-4) inhibitors

342

1597

1.72

19.26

1.3

11.68

13.63

u/l

1.71

310

1480

All influenza (not pneumonia)

187

3.50

19.15

1.3

16.26

12.63

u/l

0.69

182

Fall on same level

500

1724

1.59

19.10

1.3

14.56

14.38

u/l

0.04

446

1608

Insulin, intermediate and long-acting

314

1757

1.74

19.08

1.4

1.3

10.89

14.12

u/l

2.86

274

1632

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

218

3.31

18.99

1.4

1.3

12.06

13.48

u/l

0.24

201

Substance abuse, excluding more controls

298

1436

1.78

18.91

1.2

1.3

15.09

14.19

u/l

0.20

277

1334

Asthma (diagnoses ohter than nonallergic)

410

2095

1.63

18.82

1.3

13.12

14.10

u/l

0.33

369

1944

Unspecified acute lower respiratory infection

363

2.72

18.78

1.2

1.3

13.54

14.16

u/l

0.13

332

Coronary atherosclerosis

350

1293

1.72

18.75

1.3

12.17

15.38

u/l

1.38

318

1207

Abnormal findings on examination of blood, without diagnosis

296

1551

1.76

18.44

1.3

12.07

14.22

u/l

1.56

260

1444

Myocardial infarction

295

1167

1.79

18.41

1.3

12.43

14.67

u/l

0.72

259

1088

Insulin, fast-acting or short human

208

1068

1.96

18.36

1.4

1.3

11.12

14.38

u/l

1.65

181

982

314

1648

1.73

18.32

1.2

1.3

14.63

14.70

u/l

0.01

289

1525

Abnormal findings on diagnostic imaging of other body structures

265

3.01

18.18

1.5

1.3

12.34

12.15

u/l

0.05

245

Cerebrovascular diseases

418

1823

1.62

18.14

1.3

11.31

14.05

u/l

2.53

367

1698

ILD, hospital admissions 1, main diag only

116

476

2.47

18.10

1.3

15.54

13.16

u/l

0.48

104

436

Use of hypnotics and sedatives

500

1843

1.56

18.04

1.2

1.3

14.76

14.03

u/l

0.23

459

1707

Autoimmune diseases

504

1639

1.57

18.02

1.3

16.13

13.49

u/l

0.72

459

1523

Injuries to the head

502

1997

1.55

17.75

1.3

15.54

13.70

u/l

0.70

455

1852

Implicit fungal Sepsis

4.86

17.59

1.5

1.2

11.13

12.63

u/l

0.22

Malignant neoplasm of breast, ER-negative, including Hilmo

241

3.02

17.50

1.2

9.93

10.67

u/l

0.18

205

Infections of the skin and subcutaneous tissue

269

1507

1.77

17.48

1.3

14.70

14.61

u/l

0.02

247

1387

Major coronary heart disease event excluding revascularizations

342

1353

1.69

17.48

1.3

13.09

14.69

u/l

0.40

301

1265

Benign neoplasm of colon, rectum, anus and anal canal

367

1952

1.64

17.45

1.3

11.90

13.78

u/l

0.89

344

1796

Non-small cell lung cancer, squamous, helper endpoint

185

3.42

17.44

1.2

1.3

9.52

15.44

u/l

1.66

172

Hypokalaemia

272

2.93

17.39

1.2

16.30

11.88

u/l

0.36

248

Disorders resulting from impaired renal tubular function

4.81

17.35

1.2

8.62

10.84

u/l

0.60

Mental and behavioural disorders due to psychoactive substance use

306

1663

1.71

17.33

1.2

1.3

15.00

14.60

u/l

0.08

285

1534

Disorders of choroid and retina

433

1949

1.58

17.33

1.3

12.50

13.84

u/l

0.52

390

1808

Other CVD

151

707

2.15

17.26

1.3

13.13

13.87

u/l

0.09

133

643

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

469

1935

1.56

17.09

1.3

15.15

13.73

u/l

0.32

424

1794

Malignant melanoma

259

2.96

17.03

1.3

10.42

11.69

u/l

0.49

232

Peripheral arterial reconstruction

148

693

2.16

16.96

1.3

9.24

13.88

u/l

3.94

127

635

Acute bronchitis

227

1208

1.85

16.93

1.3

16.73

13.77

u/l

0.41

214

1110

Amputation of toe

229

3.11

16.92

1.3

10.02

14.71

u/l

1.21

210

Substance abuse

298

1643

1.71

16.91

1.2

1.3

15.09

14.63

u/l

0.09

277

1515

318

1668

1.68

16.89

1.3

14.61

14.70

u/l

0.02

293

1543

Used for control exclusion in common control thyroid runs

471

1521

1.57

16.89

1.3

14.59

13.71

u/l

0.26

430

1412

Diabetes, varying definitions

438

1627

1.58

16.85

1.3

11.29

14.78

u/l

3.87

397

1514

Hyperlipidaemia, other/unspecified

240

1219

1.82

16.83

1.4

1.3

12.30

13.32

u/l

0.24

221

1131

Diabetes mellitus

438

1625

1.58

16.72

1.3

11.32

14.78

u/l

3.82

399

1512

Invasive ventilation

175

3.42

16.71

1.4

1.3

10.80

14.53

u/l

0.75

161

Acute peritonitis

156

3.58

16.68

1.3

1.2

9.75

12.48

u/l

0.95

145

Fungal Sepsis

4.45

16.66

1.4

1.2

12.24

12.28

u/l

0.00

Symptoms and signs involving the urinary system

396

1897

1.60

16.57

1.3

13.69

13.65

u/l

0.01

365

1747

Nausea and vomiting

145

665

2.15

16.50

1.3

13.69

12.30

u/l

0.29

127

615

Disorders of gallbladder, biliary tract and pancreas

480

1976

1.54

16.46

1.3

13.36

14.07

u/l

0.23

436

1829

Vocal cord dysfunction

192

3.15

16.34

1.5

1.2

12.77

13.94

u/l

0.34

187

Alcohol use disorder, Swedish definition

296

1607

1.69

16.21

1.3

14.70

14.73

u/l

0.01

273

1485

Senile cataract

339

1253

1.66

16.09

1.3

11.52

14.02

u/l

1.83

298

1165

Convulsions, not elsewhere classified

113

478

2.35

15.96

1.3

18.52

14.86

u/l

0.36

103

446

Persons encountering health services in other circumstances, wide

540

1858

1.50

15.93

1.3

14.60

14.04

u/l

0.12

513

1697

Diabetes, insulin treatment (Kela reimbursement)

464

1833

1.53

15.69

1.3

11.61

14.61

u/l

2.62

422

1703

Small cell lung cancer

6.14

15.64

1.1

1.2

12.00

8.85

u/l

0.82

Small cell lung cancer, including Hilmo

6.14

15.64

1.1

1.2

12.00

8.85

u/l

0.82

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

142

678

2.11

15.47

1.3

20.13

11.94

u/l

4.64

132

625

Type 2 diabetes

429

1617

1.55

15.32

1.3

11.71

14.70

u/l

2.80

387

1504

Emphysema

211

3.08

15.29

1.2

1.3

19.68

12.99

u/l

0.53

194

Clear cell adenocarcinoma of kidney

4.80

15.21

1.2

1.3

10.28

10.05

u/l

0.05

Malignant melanoma, including Hilmo

333

2.60

15.18

1.3

10.37

11.69

u/l

0.61

300

Seropositive rheumatoid arthritis

144

694

2.08

15.15

1.3

20.16

12.16

u/l

4.34

134

641

Other diseases of intestines

445

1652

1.53

15.01

1.3

14.24

14.45

u/l

0.06

402

1536

Bronchiectasis

203

3.09

14.99

1.4

1.3

20.11

12.03

u/l

0.67

190

Osteopathies and chondropathies

268

1472

1.70

14.99

1.3

12.17

13.71

u/l

0.88

235

1359

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

414

1611

1.55

14.83

1.3

11.58

14.76

u/l

2.68

374

1498

Antihypertensive medication - note that there are other indications

145

356

2.16

14.73

1.3

12.00

18.42

u/l

3.00

133

337

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

291

1770

1.65

14.57

1.3

12.44

13.68

u/l

0.34

265

1633

Glomerulonephritis

223

2.95

14.48

1.4

1.3

15.02

14.04

u/l

0.09

205

Constipation

434

1983

1.52

14.48

1.3

13.05

13.70

u/l

0.22

390

1840

Dilated cardiomyopathy

402

2.42

14.44

1.2

1.3

12.27

13.45

u/l

0.09

372

Seropositive rheumatoid arthritis, wide

144

710

2.04

14.43

1.3

20.16

11.87

u/l

4.87

134

655

Other cataract

247

1080

1.74

14.40

1.3

12.84

13.74

u/l

0.25

231

1011

Other/unspecified seropositive rheumatoid arthritis

142

698

2.05

14.35

1.3

20.13

11.90

u/l

4.71

132

643

Endocrine, nutritional and metabolic diseases

293

878

1.69

14.34

1.3

13.20

15.90

u/l

0.80

270

824

Diseases of the skin and subcutaneous tissue

441

1448

1.53

14.32

1.3

12.51

14.22

u/l

1.23

405

1343

Gastroduodenal ulcer

181

969

1.87

14.15

1.3

14.01

14.14

u/l

0.01

162

906

Idiopathic gout

328

2.57

14.15

1.4

1.3

10.28

13.73

u/l

1.32

302

Alcoholic liver disease

288

2.67

14.08

1.3

19.06

14.17

u/l

0.34

270

Lung transplant status

25.42

13.99

1.1

9.32

13.75

u/l

—

Lung transplantation

25.41

13.99

1.1

9.32

13.75

u/l

—

Other disorders of kidney and ureter

368

2.44

13.76

1.3

10.51

12.78

u/l

0.72

336

Ischaemic heart disease, wide definition

376

1501

1.56

13.74

1.3

13.03

14.70

u/l

0.56

339

1394

Other retinal disorders

355

1779

1.56

13.66

1.3

11.48

13.70

u/l

1.88

318

1652

Type 1 diabetes, wide definition, subgroup 1

405

2.36

13.65

1.3

9.41

14.49

u/l

3.00

375

Rheumatoid arthritis

178

859

1.87

13.58

1.3

19.52

13.15

u/l

3.27

168

798

Fracture of femur

184

911

1.84

13.46

1.2

1.3

13.57

13.15

u/l

0.06

169

827

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

294

2.60

13.42

1.3

12.32

11.36

u/l

0.13

261

Stroke, including SAH

360

1695

1.55

13.18

1.3

10.86

13.68

u/l

3.12

320

1580

Symptoms and signs involving the digestive system and abdomen

454

1527

1.49

13.16

1.3

14.34

14.50

u/l

0.04

408

1424

Syncope and collapse

225

1121

1.72

13.11

1.3

14.47

13.67

u/l

0.13

201

1052

Misadventures to patients during surgical and medical care

352

2.43

13.11

1.4

1.3

13.18

13.20

u/l

0.00

324

Other disorders of glucose regulation and pancreatic internal secretion

177

3.08

13.06

1.3

1.2

16.65

12.33

u/l

0.22

166

Intestinal infectious diseases

513

2032

1.44

12.98

1.3

13.87

14.05

u/l

0.05

456

1893

Multiple myeloma, including Hilmo

4.29

12.93

1.2

11.30

10.75

u/l

0.08

Peripheral artery operations in Hilmo

100

448

2.25

12.89

1.3

9.38

14.64

u/l

2.81

411

Injuries to the hip and thigh

272

1518

1.63

12.89

1.3

13.46

13.50

u/l

0.01

255

1396

Pain, not elsewhere classified

119

572

2.09

12.81

1.3

14.04

13.61

u/l

0.08

110

536

Abnormalities of heart beat

149

765

1.92

12.56

1.3

1.2

10.02

14.28

u/l

4.16

127

719

Mental and behavioural disorders due to alcohol, excluding acute intoxication

230

1366

1.68

12.54

1.3

15.06

14.94

u/l

0.02

214

1263

Rheumatoid arthritis, including avohilmo

187

1054

1.78

12.53

1.3

19.22

12.42

u/l

4.13

176

964

Hodgkin lymphoma, hilmo

5.31

12.52

1.2

10.96

11.44

u/l

0.09

Certain disorders involving the immune mechanism

448

2.22

12.46

1.5

1.3

14.53

12.89

u/l

0.37

415

Diabetic retinopathy, excluding more controls

136

372

2.06

12.46

1.3

13.17

13.54

u/l

0.04

118

348

Mental and behavioural disorders due to alcohol

258

1528

1.63

12.36

1.2

1.3

14.77

14.91

u/l

0.02

240

1409

Hypotension

125

622

2.03

12.32

1.3

14.49

14.09

u/l

0.04

107

564

Polyneuropathies and other disorders of the peripheral nervous system

139

722

1.94

12.12

1.3

10.75

14.74

u/l

2.44

119

661

Myocardial infarction, strict

260

1135

1.64

12.11

1.2

1.3

12.42

14.76

u/l

0.68

228

1059

Benign neoplasm: Colon

304

1871

1.56

12.04

1.4

1.3

10.93

13.76

u/l

2.19

283

1725

Open wound of head

274

1665

1.59

11.95

1.3

13.93

u/l

0.00

253

1544

Supplementary factors related to causes of morbidity and mortality classified elsewhere

144

761

1.90

11.90

1.3

17.63

13.22

u/l

0.63

123

705

Hypertensive Renal Disease

111

3.58

11.88

1.3

1.2

6.53

12.97

u/l

5.47

104

Persons encountering health services for other counselling and medical advice, not elsewhere classified

485

1838

1.44

11.85

1.3

14.51

14.11

u/l

0.07

455

1679

Type 1 diabetes, wide definition

458

2.17

11.78

1.3

9.40

14.30

u/l

3.20

425

Persons with potential health hazards related to communicable diseases

112

539

2.07

11.75

1.2

1.3

19.02

13.48

u/l

0.67

100

501

Paralytic ileus and intestinal obstruction

155

844

1.85

11.67

1.3

15.12

13.11

u/l

0.30

142

784

Other special examinations and investigations of persons without complaint or reported diagnosis

302

965

1.59

11.65

1.3

12.53

14.33

u/l

0.96

276

910

Intestinal stricture

179

1024

1.76

11.46

1.3

14.50

13.72

u/l

0.12

163

943

Type of accident

135

709

1.91

11.39

1.3

17.71

12.82

u/l

0.67

115

658

Gastric ulcer

119

599

2.00

11.39

1.3

12.88

13.53

u/l

0.07

104

550

Seropositive rheumatoid arthritis, strict definition

339

2.35

11.32

1.3

21.68

11.76

u/l

3.47

309

Dermatitis

277

1770

1.56

11.31

1.3

14.48

13.71

u/l

0.28

254

1629

Osteoporosis

143

717

1.87

11.20

1.3

11.20

11.77

u/l

0.20

128

658

Type 1 diabetes

112

554

2.03

11.19

1.3

9.57

14.78

u/l

3.98

515

Diabetes medication

430

1766

1.45

11.13

1.3

11.84

14.61

u/l

2.48

389

1638

Abnormal results of function studies

141

3.15

11.10

1.4

1.3

12.67

12.86

u/l

0.03

133

Other embolism and thrombosis

361

2.29

11.09

1.3

24.15

13.17

u/l

0.49

336

Stroke, excluding SAH

343

1673

1.50

11.09

1.3

10.54

13.68

u/l

3.77

305

1559

Type 2 diabetes, definitions combined

399

1600

1.47

11.08

1.3

11.95

14.70

u/l

2.30

362

1487

Other soft tissue disorders, not elsewhere classified

400

1603

1.47

11.05

1.3

12.35

14.73

u/l

1.78

364

1490

Pain in limb

352

1579

1.49

10.99

1.3

11.93

14.70

u/l

2.18

322

1469

In situ neoplasms

199

1187

1.68

10.97

1.2

1.3

13.61

13.17

u/l

0.09

187

1079

Autoimmune diseases related-to ILD

355

2059

1.48

10.92

1.3

17.72

13.40

u/l

0.98

318

1910

Tuberculosis, IBD comorbidity

225

2.65

10.90

1.3

1.2

25.53

13.28

u/l

2.57

209

Respiratory tuberculosis, confirmed and not-confirmed

175

2.90

10.88

1.3

28.59

15.21

u/l

2.26

163

Respiratory tuberculosis

175

2.90

10.88

1.3

28.59

15.21

u/l

2.26

163

Finngen Rheumatological endpoints

391

1519

1.47

10.81

1.3

15.66

13.72

u/l

0.43

358

1407

Tuberculosis

204

2.73

10.74

1.3

27.32

14.29

u/l

2.43

190

Ischaemic Stroke, excluding all haemorrhages

331

1647

1.50

10.73

1.3

11.08

13.60

u/l

2.16

293

1539

Alcohol use disorder, ICD-based

208

1264

1.65

10.68

1.3

15.45

14.97

u/l

0.07

194

1167

Systemic connective tissue disorders

168

965

1.75

10.64

1.3

14.05

12.51

u/l

0.69

150

884

Type 2 diabetes, strict (exclude DM1)

399

1616

1.45

10.56

1.3

11.92

14.64

u/l

2.28

362

1500

175

1010

1.72

10.55

1.2

1.3

12.21

13.46

u/l

0.65

164

933

Diagnoses used for exclusion with ILD

148

823

1.81

10.49

1.4

1.3

13.03

14.06

u/l

0.30

137

752

Disorders of thyroid, IBD co-morbidities

205

2.44

10.36

1.4

1.2

12.20

13.05

u/l

0.23

196

Coagulation defects, purpura and other haemorrhagic conditions

100

490

2.05

10.35

1.3

13.44

12.70

u/l

0.20

452

Falls/tendency to fall

433

1516

1.43

10.34

1.3

13.40

14.20

u/l

0.27

389

1416

Amiodarone users

342

2.28

10.27

1.2

1.3

11.57

13.47

u/l

0.23

316

Osteomyelitis

176

2.82

10.18

1.3

10.74

12.54

u/l

0.41

160

Purpura and other haemorrhagic conditions

343

2.26

10.17

1.3

14.00

13.01

u/l

0.21

314

Malignant melanoma of skin, including Hilmo

263

2.45

10.13

1.2

1.3

9.74

11.73

u/l

0.92

234

Colorectal cancer

105

519

1.99

9.94

1.3

14.53

11.73

u/l

0.42

466

Other disorders of skin and subcutaneous tissue, not elsewhere classified

385

2.17

9.94

1.4

1.3

10.77

12.71

u/l

0.65

353

Tuberculosis, wide

236

2.53

9.93

1.3

25.53

14.23

u/l

2.24

219

Asthma and opportunity respiratory infection

120

3.21

9.89

1.2

14.88

12.35

u/l

0.48

113

Other and unspecified dermatitis

225

1423

1.59

9.85

1.3

13.86

13.92

u/l

0.02

207

1307

Diseases of peritoneum

255

2.45

9.83

1.3

10.33

13.34

u/l

0.86

235

Benign neoplasms

410

1586

1.43

9.82

1.3

14.69

14.77

u/l

0.01

383

1457

Symptoms and signs involving cognition, perception, emotional state and behaviour

417

2016

1.41

9.80

1.3

14.38

13.91

u/l

0.12

378

1874

Other and unspecified polyneuropathies, also in other diseases

121

648

1.88

9.73

1.3

10.56

13.21

u/l

1.38

107

589

Hernia

400

1890

1.42

9.70

1.3

13.84

13.89

u/l

0.01

367

1744

Cardiac arrest

3.33

9.63

1.3

1.2

8.63

17.00

u/l

3.93

Retention of urine

219

1132

1.59

9.52

1.3

12.86

14.23

u/l

0.57

206

1050

Intracranial trauma

223

988

1.59

9.38

1.3

15.45

14.11

u/l

0.33

199

930

Cellulitis

111

585

1.91

9.37

1.4

1.3

16.41

13.26

u/l

0.36

104

541

Unspecified haematuria

244

1313

1.55

9.32

1.4

1.3

14.36

14.00

u/l

0.08

227

1211

Amyloidosis

4.13

9.29

1.4

1.2

6.90

11.11

u/l

1.19

Methotrexate

275

2.34

9.22

1.3

17.81

13.63

u/l

0.97

257

Obesity related asthma

145

836

1.74

9.14

1.4

1.3

13.86

13.19

u/l

0.12

133

780

Factors influencing health status and contact with health services

124

327

1.91

9.12

1.3

1.2

12.58

15.50

u/l

0.78

113

311

Mycoses

130

727

1.80

9.11

1.3

12.72

12.93

u/l

0.06

110

671

Phlebitis and thrombophlebitis (not including DVT)

112

598

1.88

9.11

1.3

13.07

13.03

u/l

0.01

100

558

Viral infections characterized by skin and mucous membrane lesions

174

1054

1.65

9.10

1.3

12.53

13.39

u/l

0.25

156

974

Candidiasis

112

602

1.87

8.92

1.4

1.3

12.62

12.59

u/l

0.01

103

556

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

167

2.72

8.83

1.4

1.2

14.13

12.37

u/l

0.15

153

Other external causes of accidental injury

337

1163

1.45

8.79

1.3

12.83

14.25

u/l

0.43

309

1084

Fracture of lumbar spine and pelvis

126

705

1.79

8.79

1.4

1.3

17.07

12.47

u/l

0.60

115

643

Injuries to the abdomen, lower back, lumbar spine and pelvis

190

1176

1.60

8.76

1.4

1.3

16.75

13.16

u/l

0.69

175

1076

Malignant neoplasm of colon, including Hilmo

405

2.06

8.74

1.3

13.24

11.43

u/l

0.32

364

Cutaneous abscess, furuncle and carbuncle

112

607

1.85

8.71

1.2

1.3

15.23

13.46

u/l

0.36

103

564

Accidents

336

1163

1.45

8.64

1.3

12.82

14.25

u/l

0.43

308

1084

Type 2 diabetes, definitions combined, including avohilmo

385

1600

1.40

8.57

1.3

11.90

14.68

u/l

2.32

350

1485

Fracture of rib(s), sternum and thoracic spine

163

990

1.65

8.52

1.3

15.21

14.10

u/l

0.24

153

901

Coronary artery bypass grafting

177

809

1.64

8.50

1.3

9.72

15.53

u/l

7.02

160

753

Left ventricular outflow tract obstruction (LVOTO), broad definition

182

2.60

8.49

1.4

1.3

14.88

12.53

u/l

0.23

173

Other or unspecified ileus, impaction or obstruction

109

591

1.85

8.48

1.2

1.3

16.29

12.94

u/l

0.39

545

Malignant melanoma of skin

194

2.54

8.46

1.2

1.3

9.50

10.74

u/l

0.51

172

Presence of other functional implants

293

1397

1.46

8.30

1.3

12.52

14.05

u/l

0.42

267

1310

Amputation of foot

3.49

8.27

1.1

1.3

12.13

14.21

u/l

0.19

Other symptoms and signs involving the urinary system

302

2.20

8.26

1.5

1.3

11.23

13.65

u/l

0.63

281

Symptoms and signs concerning food and fluid intake

245

2.34

8.23

1.2

1.3

12.10

12.65

u/l

0.10

229

Lung diseases due to external agents

492

1.92

8.19

1.3

11.14

14.09

u/l

1.19

445

Malignant neoplasm of colon

303

2.19

8.18

1.3

13.73

11.63

u/l

0.28

269

Exposure to unspecified factor

405

2129

1.37

8.16

1.2

1.3

13.91

14.04

u/l

0.03

374

1964

Other arthritis (FG)

137

805

1.71

8.13

1.4

1.3

15.68

13.38

u/l

0.62

130

754

Zoster [herpes zoster]

529

1.88

8.09

1.3

10.48

12.44

u/l

1.03

485

Thyrotoxicosis with toxic multinodular goitre

141

2.80

8.07

1.5

1.3

11.31

11.85

u/l

0.10

124

Injuries to the thorax

225

1498

1.51

7.91

1.3

14.46

14.02

u/l

0.12

211

1374

Colorectal adenocarcinoma

442

1.95

7.84

1.2

1.3

10.51

11.41

u/l

0.42

400

malignant neoplasm of male genital organs

143

512

1.71

7.79

1.3

15.18

13.53

u/l

0.23

130

474

Aortic valve malfunction, age under 60 years

167

2.59

7.75

1.4

1.3

15.73

12.39

u/l

0.32

159

Amyloidosis, other/unspecified

4.06

7.66

1.3

1.2

5.44

11.30

u/l

4.24

Biguanides

403

1806

1.36

7.63

1.3

13.08

14.34

u/l

0.58

367

1670

Other (not insulin) diabetes medications

401

1748

1.36

7.59

1.3

12.00

14.52

u/l

2.03

363

1620

Delirium, not induced by alcohol and other psychoactive substances

422

1.95

7.51

1.1

1.3

11.13

11.96

u/l

0.23

384

L02BA Anti-estrogens

269

2.20

7.47

1.3

1.2

10.93

10.88

u/l

0.01

243

Thyrotoxicosis

529

1.84

7.46

1.4

1.3

10.85

13.11

u/l

1.04

487

Other and unspecified local infections of skin and subcutaneous tissue

213

2.36

7.43

1.3

1.2

12.29

12.61

u/l

0.04

193

Unspecified fall

227

1514

1.48

7.39

1.3

16.88

13.35

u/l

0.82

205

1399

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

416

1.94

7.38

1.2

1.3

16.68

13.27

u/l

0.76

389

Diverticular disease of intestine

335

1541

1.39

7.28

1.3

14.17

13.72

u/l

0.11

310

1432

Other infectious diseases

234

2.28

7.28

1.4

1.3

20.88

13.72

u/l

0.76

215

Other specified/unspecified arthritis

121

710

1.71

7.27

1.4

1.3

16.32

13.30

u/l

0.79

115

665

Fitting and adjustment of other devices

167

957

1.58

7.25

1.4

1.3

11.68

13.70

u/l

1.19

159

891

Elevated blood glucose level

179

2.48

7.24

1.2

1.3

14.55

11.84

u/l

0.51

165

General examination and investigation of persons without complaint and reported diagnosis

268

962

1.46

7.23

1.3

16.74

14.36

u/l

0.32

241

907

Chronic apical periodontitis

455

1956

1.33

7.18

1.3

15.94

13.58

u/l

0.81

425

1795

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

249

2.23

7.12

1.3

10.84

13.88

u/l

0.76

224

Other local infections of skin and subcutaneous tissue

230

2.28

7.11

1.3

1.2

12.17

12.53

u/l

0.05

208

Malignant neoplasm of prostate

141

507

1.67

7.09

1.3

15.15

13.54

u/l

0.22

128

470

Sequelae of cerebrovascular disease

214

1245

1.49

7.01

1.3

10.59

14.09

u/l

3.69

194

1159

Medical observation and evaluation for suspected diseases and conditions

272

965

1.44

7.00

1.3

13.47

14.33

u/l

0.22

248

910

Candidiasis

286

2.11

6.84

1.3

12.30

11.65

u/l

0.14

263

Vascular disorders of the intestines

216

2.29

6.78

1.3

18.37

10.48

u/l

0.44

200

External causes of morbidity and mortality

249

857

1.46

6.74

1.3

13.72

14.89

u/l

0.24

229

807

Other gastritis (incl. Duodenitis)

114

674

1.70

6.71

1.5

1.3

10.79

13.75

u/l

1.98

101

627

Thyrotoxicosis, other and/or unspecified

405

1.91

6.68

1.4

1.3

10.50

12.65

u/l

0.94

373

Chronic ulcer of skin, not elsewhere classified

199

2.33

6.66

1.4

1.3

9.40

14.61

u/l

1.41

180

Small cell lung cancer, helper endpoint

3.09

6.65

1.1

1.3

12.00

12.29

u/l

0.04

Asthma, including avohilmo

476

2054

1.30

6.64

1.3

14.00

14.13

u/l

0.03

429

1905

Dysphagia

124

752

1.66

6.63

1.3

10.12

12.85

u/l

2.15

119

700

Pyogenic arthritis

170

2.43

6.52

1.3

10.17

14.03

u/l

0.76

157

Medicines for HER+ breast cancer

120

686

1.66

6.50

1.2

1.3

12.54

11.63

u/l

0.26

111

622

Other other unspecified disorders of the circulatory system

3.10

6.48

1.3

1.2

7.54

13.71

u/l

1.64

Disorders of other endocrine glands

163

1043

1.54

6.48

1.2

1.3

13.99

12.29

u/l

0.55

145

957

Diabetic retinopathy

180

737

1.53

6.39

1.3

12.20

12.45

u/l

0.03

157

678

Diarrhoea and gastroenteritis of presumed infectious origin

402

2011

1.32

6.34

1.3

14.47

13.99

u/l

0.14

361

1871

Sequelae of external causes of morbidity and mortality

120

731

1.65

6.33

1.4

1.3

12.00

13.22

u/l

0.37

106

670

Cholelithiasis, broad definition with cholecystitis

371

1881

1.33

6.19

1.3

13.37

13.63

u/l

0.06

339

1740

Diaphragmatic hernia

174

1163

1.50

6.15

1.3

13.19

12.62

u/l

0.19

160

1069

Vascular diseases of the intestine

117

2.68

6.00

1.2

26.12

12.56

u/l

0.44

110

Malignant neoplasm of prostate, including Hilmo

139

518

1.60

6.00

1.3

14.62

13.57

u/l

0.14

126

480

Intracranial injury

247

1674

1.40

5.98

1.3

15.05

13.78

u/l

0.37

221

1557

Other condition

288

2.02

5.98

1.3

11.57

14.05

u/l

0.65

268

Diabetic maculopathy, excluding more controls

275

2.05

5.96

1.4

1.3

9.94

13.58

u/l

1.09

255

Open wound of lower leg

330

1.95

5.94

1.3

12.44

12.93

u/l

0.11

306

Other necrotizing vasculopathies

191

2.27

5.90

1.3

12.00

11.02

u/l

0.22

175

Abdominal and pelvic pain

399

1527

1.31

5.86

1.3

15.07

14.50

u/l

0.15

369

1424

Suicide or other Intentional self-harm

431

1.81

5.85

1.2

1.3

16.87

12.86

u/l

0.92

401

Other antidepressants

444

1760

1.29

5.85

1.3

14.78

13.91

u/l

0.26

412

1622

Actinic keratosis

222

1453

1.42

5.83

1.2

1.3

13.06

12.76

u/l

0.08

208

1329

Gastrointestinal diseases

181

603

1.51

5.81

1.3

12.83

14.42

u/l

0.55

164

566

235

1540

1.40

5.79

1.2

1.3

13.03

12.87

u/l

0.04

219

1413

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

455

1.78

5.76

1.2

1.3

16.68

12.93

u/l

0.88

423

Concussion

178

984

1.48

5.74

1.3

15.70

14.11

u/l

0.34

160

926

Mycoses

324

2120

1.33

5.71

1.3

14.89

14.09

u/l

0.24

297

1957

Periodontitis

394

2027

1.30

5.70

1.3

13.34

14.14

u/l

0.34

367

1864

Other symptoms and signs involving the digestive system and abdomen

342

1.91

5.70

1.4

1.3

16.98

11.91

u/l

0.40

319

Injury, poisoning and certain other consequences of external causes

202

692

1.47

5.69

1.3

14.23

15.38

u/l

0.19

186

650

Asthma, hospital admissions , main diagnosis only

313

2074

1.33

5.60

1.3

12.98

14.24

u/l

0.40

278

1921

Acute pancreatitis

572

1.69

5.57

1.3

18.61

13.59

u/l

0.44

531

Colon adenocarcinoma

235

2.10

5.57

1.2

1.3

11.11

11.88

u/l

0.21

209

Skin changes due to chronic exposure to nonionizing radiation

224

1476

1.40

5.56

1.2

1.3

13.04

12.73

u/l

0.08

210

1351

Benign neoplasm: Ascending colon

439

1.79

5.55

1.6

1.3

8.53

12.57

u/l

2.69

403

Benzodiazepine use

403

2150

1.29

5.55

1.3

14.74

13.82

u/l

0.27

370

1985

Use of rivastigmine

601

0.38

5.51

1.2

1.3

32.39

12.71

u/l

0.50

548

Multiple myeloma and malignant plasma cell neoplasms

141

2.44

5.47

1.4

1.2

11.29

12.12

u/l

0.13

132

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

310

1.92

5.41

1.6

1.3

9.77

12.56

u/l

1.18

286

Examination and observation for other reasons

230

947

1.41

5.41

1.2

15.34

14.43

u/l

0.16

216

896

Chronic periodontitis, including avohilmo

390

2024

1.29

5.40

1.3

13.37

14.16

u/l

0.33

363

1861

Persons encountering health services for examination and investigation

265

965

1.38

5.38

1.3

14.48

14.33

u/l

0.03

243

910

Barrett oesophagus

124

2.52

5.38

1.3

11.12

13.31

u/l

0.43

115

L02BG Aromatase inhibitors

102

624

1.64

5.33

1.2

1.3

12.66

11.62

u/l

0.27

564

Gastro-oesophageal reflux disease

269

1719

1.35

5.30

1.3

13.52

14.32

u/l

0.17

245

1596

Other nutritional deficiencies

218

1474

1.39

5.27

1.3

14.69

14.45

u/l

0.04

201

1362

Diabetic retinopathy, strict definition

451

1.71

5.26

1.3

8.90

13.07

u/l

2.91

420

Use of anticholinesterases

104

1299

0.63

5.24

1.3

20.51

12.63

u/l

1.11

1184

N06DA Anticholinesterases

104

1299

0.63

5.24

1.2

1.3

20.51

12.63

u/l

1.11

1184

Alcohol dependence

125

809

1.55

5.21

1.3

16.62

14.60

u/l

0.23

118

748

Other viral diseases

507

1.69

5.15

1.2

1.3

13.38

13.78

u/l

0.09

472

Noninfective enteritis and colitis

172

1190

1.45

5.14

1.3

20.68

13.27

u/l

0.73

151

1102

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

288

1.92

5.14

1.5

1.3

9.75

12.48

u/l

1.04

266

Leisure time condition

435

1.75

5.13

1.3

21.64

12.70

u/l

0.75

401

Sub-endpoint used in defining T1D endpoints

123

784

1.55

5.09

1.3

9.45

13.54

u/l

3.56

102

719

Sleep apnoea

380

1916

1.29

5.04

1.3

14.03

14.33

u/l

0.10

353

1765

Myocardial infarction, without ST-elevation

235

1571

1.37

5.01

1.3

12.07

13.76

u/l

0.40

204

1458

Fracture of lower leg, including ankle

212

1517

1.39

4.99

1.3

14.79

14.21

u/l

0.11

194

1407

Sequelae with surgical and medical care as external cause

577

1.64

4.92

1.4

1.3

11.86

12.74

u/l

0.23

529

Other skin changes

547

1.65

4.90

1.3

10.26

13.28

u/l

1.52

499

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

119

775

1.54

4.85

1.3

10.94

13.05

u/l

1.42

109

722

Acute upper respiratory infections of multiple and unspecified sites

269

1494

1.34

4.84

1.3

12.64

14.31

u/l

1.03

248

1373

Malignant neoplasm of rectum

182

2.15

4.80

1.4

1.2

15.71

10.52

u/l

0.34

162

Other noninfective gastroenteritis and colitis

596

1.61

4.79

1.3

18.98

12.01

u/l

0.63

553

Fracture of foot, except ankle

468

1.69

4.74

1.3

14.29

13.96

u/l

0.05

434

Other systemic involvement of connective tissue (FG)

107

675

1.57

4.74

1.2

1.3

14.48

12.00

u/l

0.93

623

DVT of lower extremities

576

1.62

4.72

1.2

1.3

13.15

13.58

u/l

0.08

531

Other functional intestinal disorders

193

1286

1.40

4.72

1.2

1.3

14.69

13.63

u/l

0.16

163

1198

Neurological diseases, wide definition

223

1.76

4.70

1.2

11.38

13.82

u/l

0.87

214

Chronic diseases of tonsils and adenoids

134

1248

0.68

4.70

1.3

16.84

13.93

u/l

0.22

125

1153

Degeneration of macula and posterior pole

256

1527

1.34

4.69

1.3

12.06

13.39

u/l

0.66

232

1411

Essential (haemorrhagic) thrombocythaemia

3.36

4.61

1.1

1.3

8.44

9.42

u/l

0.26

Adenocarcinoma and papilloma adenocarcinoma of rectum

179

2.13

4.58

1.3

1.2

9.70

10.49

u/l

0.23

159

Malignant neoplasm of rectum, including Hilmo

240

1.97

4.57

1.3

14.15

11.75

u/l

0.17

213

Atrial septal defect

3.34

4.56

1.6

1.1

10.25

11.84

u/l

0.22

Viral infections characterized by skin and mucous membrane lesions

318

2111

1.29

4.55

1.3

13.08

14.31

u/l

0.58

295

1948

Other infectious diseases

201

2.05

4.48

1.5

1.3

23.15

13.83

u/l

0.81

188

Other viral diseases

100

634

1.57

4.46

1.2

1.3

12.76

13.93

u/l

0.40

590

Carbimazole or st.post thyroidectomy, condition for graves disease

380

1.74

4.42

1.4

1.3

11.75

11.68

u/l

0.02

346

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

189

2.07

4.39

1.3

1.2

9.50

10.63

u/l

0.37

167

Hypercalcemia

100

2.52

4.39

1.2

22.08

12.85

u/l

0.69

Decubitus ulcer and pressure area

203

2.04

4.38

1.3

10.33

15.22

u/l

1.19

186

Benign neoplasm: Sigmoid colon

612

1.58

4.36

1.4

1.3

9.37

12.09

u/l

2.08

554

Use of disulfiram, acamprosate or naltrexone

138

2.26

4.31

1.4

1.3

12.16

12.05

u/l

0.03

132

Zoster [herpes zoster]

215

1574

1.35

4.30

1.3

11.54

13.07

u/l

1.08

200

1445

Selective deficiency of immunoglobulin G [IgG] subclasses

11.94

4.30

1.6

1.2

7.57

12.00

u/l

—

Disorders of parathyroid gland

576

1.58

4.28

1.2

1.3

12.16

12.09

u/l

0.01

530

Sulfonylureas

207

1215

1.36

4.27

1.3

11.98

13.55

u/l

0.51

184

1127

Other symptoms and signs involving cognitive functions and awareness

225

1535

1.34

4.25

1.3

14.27

13.54

u/l

0.19

206

1427

Congenital malformations, deformations and chromosomal abnormalities

166

1130

1.40

4.22

1.4

1.3

10.00

14.78

u/l

4.65

152

1048

Other systemic involvement of connective tissue

111

737

1.51

4.20

1.2

1.3

14.64

12.37

u/l

0.88

680

Acute pancreatitis (for exclusion)

618

1.56

4.19

1.3

18.61

13.16

u/l

0.49

568

Chronic gastritis

132

909

1.46

4.17

1.3

15.35

13.62

u/l

0.20

119

841

Genitourinary diseases

214

788

1.36

4.17

1.3

13.37

15.95

u/l

0.88

197

747

Open wound of ankle and foot

207

1.99

4.15

1.2

1.3

12.62

13.71

u/l

0.19

190

Any prescribed medicine buy

+∞

4.15

1.4

0.0

8.40

—

u/l

—

Unstable angina pectoris

191

1103

1.37

4.13

1.4

1.3

12.63

14.83

u/l

0.48

168

1029

Dermatitis and eczema

423

2123

1.24

4.10

1.3

13.68

14.12

u/l

0.19

393

1956

Angina pectoris

246

1245

1.32

4.07

1.4

1.3

12.32

14.61

u/l

0.63

223

1162

Mental and behavioural disorders due to tobacco

168

2.09

4.07

1.2

1.3

12.51

12.12

u/l

0.08

155

Smoking dependency

168

2.09

4.07

1.2

1.3

12.51

12.18

u/l

0.07

153

Cholelithiasis

340

1861

1.26

4.00

1.3

12.09

13.57

u/l

0.78

313

1720

Injuries to the ankle and foot

212

1413

1.33

3.99

1.3

13.75

14.98

u/l

0.40

186

1311

Sequelae of injuries, of poisoning and of other consequences of external causes

547

1.58

3.97

1.3

13.13

13.41

u/l

0.05

509

Exposure to other specified factors

258

1828

1.30

3.97

1.3

16.55

13.99

u/l

0.54

247

1673

Pustulosis palmaris et plantaris

2.83

3.96

1.0

1.2

12.69

10.41

u/l

0.42

Superficial injury of head

603

1.55

3.95

1.2

1.3

19.93

13.10

u/l

0.67

556

Chronic periodontitis, complicated

226

1707

1.31

3.87

1.3

14.47

13.90

u/l

0.19

209

1573

Fracture of shoulder and upper arm

146

1039

1.41

3.86

1.2

1.3

15.28

12.95

u/l

0.33

133

953

Dizziness and giddiness

303

1895

1.27

3.86

1.3

12.33

13.43

u/l

0.70

272

1759

Corns and callosities

146

2.14

3.80

1.2

1.3

13.52

11.00

u/l

0.37

135

Other neurological diseases

322

2015

1.26

3.80

1.3

14.11

13.35

u/l

0.20

292

1866

Obesity, other/unspecified

657

1.51

3.79

1.4

1.3

13.42

13.49

u/l

0.01

607

Nonalcoholic fatty liver disease

153

2.10

3.77

1.4

1.3

9.65

11.03

u/l

0.69

138

Retinal vascular disorders

408

1.65

3.73

1.3

10.34

13.12

u/l

1.05

369

Ulcer of oesophagus

202

1.94

3.72

1.3

1.2

10.72

13.11

u/l

0.67

185

Other and unspecified immunodeficiencies with predominantly antibody defects

6.76

3.68

2.0

1.2

13.50

13.00

u/l

—

Paracetamol or NSAID medication

203

1.69

3.67

1.2

1.3

12.98

14.18

u/l

0.13

186

Hypoparathyroidism

2.71

3.66

1.3

1.2

12.89

10.85

u/l

0.33

Congenital malformations, deformations and chromosomal abnormalities

184

1265

1.34

3.64

1.4

1.3

10.27

15.20

u/l

5.20

169

1172

Inflammatory diseases of the central nervous system

156

2.06

3.60

1.0

1.2

10.15

12.18

u/l

0.54

146

Cholecystitis

436

1.61

3.57

1.3

19.89

13.58

u/l

0.46

401

Sensorineural hearing loss

342

1872

1.24

3.57

1.3

13.23

13.70

u/l

0.19

305

1740

Retinal vascular occlusion

398

1.64

3.56

1.3

10.45

12.71

u/l

0.80

361

Symptoms and signs involving the skin and subcutaneous tissue

262

2017

1.27

3.55

1.3

13.07

13.71

u/l

0.25

246

1856

Secondary thrombocytopenia

5.38

3.52

1.1

1.2

11.89

12.12

u/l

—

Obesity

195

1426

1.32

3.50

1.3

12.99

14.71

u/l

0.70

181

1319

Focal epilepsy

566

1.52

3.46

1.2

1.3

11.49

12.64

u/l

0.43

519

Respiratory tuberculosis, not confirmed

132

2.14

3.46

1.3

1.2

27.09

15.83

u/l

0.88

121

Triptan medication for migraine, single purchase ok

108

1051

0.70

3.45

1.3

12.90

13.92

u/l

0.28

103

974

Migraine, single triptan purchase ok & required. ICD-code if available is included

108

1051

0.70

3.45

1.3

12.90

13.92

u/l

0.28

103

974

Dental operations

295

1200

1.26

3.45

1.3

13.54

13.10

u/l

0.11

270

1111

Childhood asthma (age<16)

7.89

3.42

1.3

1.0

10.14

6.14

u/l

—

Vitreous haemorrhage

259

1.78

3.42

1.3

11.32

13.46

u/l

0.44

237

Obesity and other hyperalimentation

195

1430

1.32

3.41

1.3

12.99

14.70

u/l

0.70

181

1323

Benign neoplasm: Rectum, anus and anal canal

667

1.47

3.38

1.3

12.44

13.14

u/l

0.09

607

Hyperparathyroidism

492

1.55

3.38

1.2

1.3

11.58

12.48

u/l

0.20

452

Personality disorders, excluding more controls

350

1.66

3.36

1.2

1.3

21.23

13.80

u/l

0.48

327

Conductive and sensorineural hearing loss

347

1905

1.23

3.36

1.3

13.32

13.67

u/l

0.13

310

1771

Chronic laryngitis and laryngotracheitis

374

1.64

3.34

1.4

1.2

12.32

13.18

u/l

0.20

345

Aortic aneurysm

136

966

1.39

3.34

1.3

10.43

14.83

u/l

3.97

129

898

Injury of unspecified body region

169

1.96

3.28

1.4

1.2

11.32

12.23

u/l

0.17

155

Diseases of the musculoskeletal system and connective tissue

180

674

1.34

3.26

1.3

1.2

13.01

15.18

u/l

0.72

166

633

123

827

1.40

3.24

1.3

12.84

12.77

u/l

0.01

111

747

Osteoporosis with pathological fracture (FG)

170

1.95

3.24

1.4

1.2

9.07

9.97

u/l

0.23

155

Any mental disorder

426

1770

1.21

3.23

1.3

16.53

13.69

u/l

0.86

393

1642

Carcinoma in situ of skin of upper limb, including shoulder

2.47

3.23

1.1

1.2

14.89

14.41

u/l

0.03

Obesity due to excess calories

140

1025

1.37

3.22

1.4

1.3

12.65

14.02

u/l

0.53

130

950

Pustular psoriasis

2.45

3.22

1.0

1.2

12.79

10.54

u/l

0.46

Systemic sclerosis,strict definition

6.47

3.20

1.0

1.1

10.29

14.45

u/l

—

Contact with and exposure to communicable diseases

346

1.64

3.19

1.2

1.3

13.16

14.22

u/l

0.16

324

Fall on and from stairs and steps

668

1.46

3.17

1.3

19.12

12.78

u/l

0.63

614

Other reaction to severe stress, and adjustment disorders

562

1.50

3.16

1.3

1.2

11.71

13.34

u/l

0.69

521

Psoriasis

104

727

1.43

3.14

1.2

1.3

14.57

13.17

u/l

0.33

674

Emotionally unstable personality disorder

2.25

3.12

1.4

1.3

15.00

12.05

u/l

0.42

Weight loss

260

1.74

3.10

1.2

1.3

12.30

13.43

u/l

0.19

238

Arterial embolism and thrombosis

173

1.92

3.09

1.4

1.3

7.36

14.15

u/l

4.48

159

Benign neoplasm: Colon, unspecified

123

890

1.39

3.07

1.5

1.3

11.00

14.07

u/l

1.74

109

814

Arthropathies

319

1311

1.23

3.06

1.3

13.62

14.00

u/l

0.11

293

1217

Diseases of pulp and periapical tissues, including avohilmo

411

1773

1.20

3.05

1.3

14.18

13.63

u/l

0.16

384

1625

Noninfectious colitis NAS

299

1.68

3.04

1.3

24.98

11.94

u/l

0.62

277

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

10.39

3.01

1.2

1.0

9.40

9.00

u/l

—

Diseases of the eye and adnexa

252

999

1.26

3.00

1.3

12.68

15.35

u/l

1.28

234

930

Other mosquito-borne viral fevers

10.16

2.99

1.0

1.2

8.60

7.00

u/l

—

Previous suicide attempt

10.10

2.98

1.6

1.2

8.40

7.60

u/l

—

Benign neoplasm: Rectum

588

1.47

2.95

1.3

12.08

13.01

u/l

0.11

536

Exclusions for E4_PCOS_BROAD

340

1.62

2.95

1.2

1.3

15.18

12.49

u/l

0.35

313

Soft tissue disorders

378

1615

1.21

2.93

1.3

11.51

14.75

u/l

3.11

343

1501

Sleep apnoea, including avohilmo

376

1938

1.20

2.92

1.3

14.01

14.29

u/l

0.09

350

1785

Disorders of skin appendages

141

1051

1.34

2.91

1.3

16.87

13.75

u/l

0.25

130

969

Coeliac disease

228

1.76

2.90

1.4

1.3

10.20

12.22

u/l

0.68

213

Unspecific neurodegenerative disorder

155

1392

0.76

2.89

1.2

1.3

23.40

11.99

u/l

2.09

137

1283

Disorders of plasma-protein metabolism, not elsewhere classified

6.79

2.88

1.2

1.3

8.17

8.33

u/l

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

6.78

2.88

1.2

1.1

12.17

6.89

u/l

—

Focal epilepsy, strict definition

542

1.48

2.87

1.2

1.3

11.70

12.75

u/l

0.35

496

Focal epilepsy, mode (most common among epilepsy diagnosis)

494

1.50

2.86

1.2

1.3

11.38

12.73

u/l

0.45

455

Other and unspecified vascular occlusions

313

1.64

2.84

1.3

11.61

13.05

u/l

0.34

282

Transient ischemic attack

249

1620

1.25

2.84

1.3

14.21

13.43

u/l

0.15

222

1514

Alzheimer disease, including avohilmo

132

1245

0.74

2.83

1.2

1.3

24.51

12.08

u/l

1.94

115

1137

Pain (limb, back, neck, head abdominally)

292

1187

1.23

2.82

1.3

14.25

14.63

u/l

0.08

263

1111

Dental pulpitis, including avohilmo

181

1510

0.78

2.82

1.2

1.3

15.02

14.75

u/l

0.07

168

1393

Epilepsy

123

901

1.36

2.82

1.2

1.3

11.72

13.62

u/l

0.97

112

843

Other diseases of anus and rectum

129

953

1.35

2.82

1.3

11.39

13.13

u/l

0.75

115

886

Diabetic maculopathy

324

1.61

2.82

1.4

1.3

9.94

11.72

u/l

0.60

300

Injuries to unspecified part of trunk, limb or body region

223

1.76

2.81

1.4

1.3

10.56

12.11

u/l

0.42

202

Other specified/unspecified hearing loss

231

1.74

2.79

1.2

1.3

16.94

12.76

u/l

0.53

212

Schizophrenia or delusion, excluding more controls

589

1.45

2.78

1.3

15.05

12.75

u/l

0.77

541

Spondyloarthritis

449

1.52

2.78

1.2

1.3

23.02

13.29

u/l

0.75

415

Exclusions for E4_PCOS_CONSORTIUM

176

848

1.30

2.76

1.2

1.3

11.95

12.26

u/l

0.13

161

778

Spondylopathies

328

1619

1.21

2.76

1.3

14.38

13.97

u/l

0.09

300

1499

Status post-ami

142

812

1.34

2.76

1.3

10.08

14.80

u/l

5.19

129

757

Other diseases of pancreas

217

1.76

2.76

1.3

13.44

11.86

u/l

0.24

201

Covid-19 suspected case

347

1.59

2.74

1.3

18.04

11.91

u/l

0.96

323

Maze procedure for atrial fibrillation

6.18

2.72

1.3

6.33

6.50

u/l

—

Neurological diseases

299

1229

1.22

2.70

1.3

13.28

13.93

u/l

0.16

271

1145

Caries of dentine, including avohilmo

338

1435

1.20

2.63

1.3

13.18

12.93

u/l

0.09

313

1321

Other disorders of ear

358

1969

1.19

2.58

1.3

12.81

14.11

u/l

0.67

321

1829

Acute epiglottitis

3.64

2.58

2.0

1.2

14.44

9.68

u/l

—

167

1131

1.29

2.58

1.2

1.3

12.69

12.78

u/l

0.02

152

1034

Unspecified chronic bronchitis

2.20

2.57

1.6

1.3

11.00

13.38

u/l

0.39

Other hearing loss

145

1087

1.31

2.54

1.3

13.85

13.40

u/l

0.12

127

1006

Inguinal hernia

258

1407

1.23

2.54

1.3

14.52

14.59

u/l

0.01

242

1306

Nerve, nerve root and plexus disorders

407

2119

1.18

2.54

1.3

12.67

14.13

u/l

0.98

366

1964

Other and unspecified effects of external causes

508

1.46

2.53

1.3

14.74

12.31

u/l

0.64

468

Other diseases of liver

411

1.51

2.52

1.3

9.93

12.96

u/l

1.55

381

Insomnia

183

1679

0.79

2.49

1.3

13.38

14.46

u/l

0.34

168

1543

Dermatophytosis

381

1.53

2.47

1.4

1.3

12.49

13.45

u/l

0.21

351

Procreative management

390

1.48

2.46

1.2

25.73

12.79

u/l

0.63

360

Disease of hard tissues of teeth, NOS

152

1026

0.77

2.44

1.4

1.3

17.32

13.34

u/l

0.75

145

932

Injuries to the elbow and forearm

231

1653

1.23

2.43

1.2

1.3

15.78

13.57

u/l

0.45

207

1523

Malignant neoplasm of bladder

181

1.77

2.42

1.3

9.88

11.20

u/l

0.43

164

Use of memantine

1084

0.73

2.41

1.3

26.36

12.16

u/l

1.40

989

Use of other anti-dementia drugs

1084

0.73

2.41

1.3

26.36

12.16

u/l

1.40

989

Papulosquamous disorders

139

1069

1.30

2.40

1.2

1.3

15.53

13.27

u/l

0.78

122

996

Dental caries, including avohilmo

325

1391

1.20

2.39

1.3

12.84

12.93

u/l

0.03

301

1278

6.40

2.38

1.4

1.1

13.00

14.50

u/l

—

ILD and respiratory illness in diseases classified elsewhere

6.38

2.38

1.4

1.1

13.00

14.50

u/l

—

Psoriasis vulgaris

474

1.46

2.38

1.3

15.77

13.44

u/l

0.42

443

Dentofacial anomalies [including malocclusion]

105

1132

0.74

2.37

1.3

13.98

14.00

u/l

0.01

1049

Disorders of eyelid, lacrimal system and orbit

327

2092

1.19

2.37

1.3

11.61

13.80

u/l

2.05

305

1928

Other chondrocalcinosis

2.87

2.36

1.0

1.2

8.27

11.36

u/l

0.56

Injuries to the knee and lower leg

433

2066

1.16

2.34

1.3

13.28

14.19

u/l

0.37

391

1918

Traumatic subdural haemorrhage

482

1.44

2.30

1.5

1.2

13.32

12.63

u/l

0.18

451

Dementia in Alzheimer disease

690

0.67

2.29

1.3

20.37

11.79

u/l

0.57

637

Other disorders of bone

364

1.51

2.28

1.3

15.38

12.89

u/l

0.48

338

Schizophrenia, schizotypal and delusional disorders

629

1.39

2.28

1.3

15.01

13.53

u/l

0.40

584

Personality disorders

389

1.49

2.26

1.2

21.23

13.62

u/l

0.49

360

Disorders of continuity of bone

163

1.78

2.26

1.4

1.2

12.82

12.65

u/l

0.02

151

Assault by sharp object

3.92

2.25

1.0

1.1

16.71

11.17

u/l

—

Infections with a predominantly sexual mode of transmission

373

1.50

2.24

1.3

1.2

16.02

12.82

u/l

0.83

346

Erectile dysfunction, exclusion

5.72

2.23

1.4

1.2

6.20

9.78

u/l

—

Benign neoplasm: Connective and other soft tissue of thorax

5.69

2.23

1.0

1.3

7.60

12.00

u/l

—

Embolic stroke

164

1.78

2.22

1.2

1.3

11.17

15.06

u/l

0.64

154

Marginal zone B-cell lymphoma

5.62

2.22

1.2

1.0

8.00

10.44

u/l

—

Unspecified threat to breathing

5.61

2.22

1.4

1.0

8.80

11.89

u/l

—

Myeloid leukaemia

2.21

2.22

1.3

1.2

10.75

13.71

u/l

0.39

Crystal arthropathies, rheuma endpoint

2.43

2.21

1.2

8.31

10.67

u/l

0.52

Schizophrenia or delusion

625

1.38

2.19

1.3

15.05

13.54

u/l

0.41

580

Fracture of skull and facial bones

508

1.42

2.18

1.2

1.3

15.95

12.98

u/l

0.72

476

Cachexia

3.78

2.17

1.4

1.3

27.43

12.89

u/l

—

Benign neoplasm: Small intestine

108

1.96

2.16

1.1

1.2

11.75

11.74

u/l

0.00

Arthropod-borne viral fevers and viral haemorrhagic fevers

443

1.45

2.15

1.2

1.3

11.64

12.22

u/l

0.12

406

Acute sinusitis

143

1038

1.28

2.14

1.3

20.69

13.92

u/l

0.59

131

957

Shoulder lesions

301

1537

1.19

2.14

1.3

13.22

14.48

u/l

0.59

269

1429

Diseases of oral cavity, salivary glands and jaws

270

1157

1.20

2.13

1.3

12.83

13.31

u/l

0.16

244

1053

Hypothyroidism, strict autoimmune

249

1360

1.20

2.11

1.3

13.09

13.36

u/l

0.05

234

1259

Dementia, including avohilmo

172

1465

0.81

2.08

1.2

1.3

21.03

12.06

u/l

1.70

153

1357

Sleep disorders

200

1762

0.82

2.08

1.3

12.98

14.42

u/l

0.55

184

1619

Moderate visual impairment, binocular

2.09

2.07

1.1

1.2

12.35

13.15

u/l

0.10

Viral and other specified intestinal infections

277

1.55

2.07

1.3

1.2

13.46

13.05

u/l

0.06

262

Benign neoplasm: Skin of trunk

2.08

2.07

1.4

1.2

9.24

10.74

u/l

0.42

Hepatomegaly and splenomegaly, not elsewhere classified

4.05

2.04

1.0

1.5

14.50

9.87

u/l

—

Agoraphobia

4.01

2.04

1.5

1.1

16.17

12.47

u/l

—

Iridocyclitis

567

1.38

2.02

1.3

13.29

13.37

u/l

0.02

525

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

181

1431

1.23

2.00

1.4

1.3

12.51

14.22

u/l

1.03

168

1321

Other and unspecified disorders of vitreous body

1270

0.76

2.00

1.3

13.09

13.38

u/l

0.08

1168

Retinal detachments and breaks

157

1259

1.25

2.00

1.3

13.35

14.09

u/l

0.10

145

1165

Diabetic neuropathy

374

1.47

2.00

1.2

1.3

11.04

12.84

u/l

0.45

339

Gonarthrosis, primary, with knee surgery

184

1790

0.82

1.99

1.3

11.97

13.73

u/l

1.28

174

1646

Macular pucker

518

1.39

1.99

1.3

11.66

13.79

u/l

0.74

471

Urticaria and erythema

740

1.33

1.99

1.3

14.62

12.78

u/l

0.50

686

Other strabismus

384

1.46

1.97

1.3

15.27

12.19

u/l

0.64

359

Eustachian salpingitis and obstruction

2.08

1.96

1.4

1.2

16.38

11.47

u/l

0.71

Benign neoplasm of other and ill-defined parts of digestive system

503

1.40

1.95

1.2

1.3

10.94

12.51

u/l

0.51

459

Disorders of eyelid in diseases classified elsewhere

2.37

1.95

1.2

1.3

8.08

12.20

u/l

1.43

Viral and other specified intestinal infections

404

1.43

1.95

1.3

13.20

13.09

u/l

0.02

378

Liposarcoma

4.61

1.95

1.0

1.3

15.20

11.09

u/l

—

Dissocial personality disorder

3.78

1.94

1.5

1.1

22.67

9.00

u/l

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

130

1015

1.27

1.93

1.3

12.44

13.81

u/l

0.48

117

939

Statin medication

205

949

1.22

1.89

1.3

12.11

15.73

u/l

1.60

187

884

Benign neoplasm: Skin of other and unspecified parts of face

291

1.52

1.89

1.2

1.3

9.73

11.61

u/l

0.72

266

Right hemicolectomy

181

1.67

1.88

1.2

1.3

11.36

14.43

u/l

0.51

169

Alcohol abuse, main dg, excluding more controls

340

1.47

1.88

1.1

1.3

14.47

13.35

u/l

0.22

316

Hyperfunction of pituitary gland

2.32

1.87

1.1

1.2

13.67

11.57

u/l

0.36

Perforation of tympanic membrane

228

1.58

1.87

1.3

12.77

11.49

u/l

0.30

209

Dementia

163

1378

0.81

1.87

1.2

1.3

21.89

12.06

u/l

1.75

142

1277

Disorders of sclera, cornea, iris and ciliary body

180

1482

1.22

1.82

1.3

13.53

14.71

u/l

0.32

164

1366

Mental disorders, not otherwise specified

101

1.89

1.80

1.1

1.2

11.79

11.08

u/l

0.15

Hyperplasia of prostate

193

903

1.22

1.79

1.4

1.3

15.44

13.87

u/l

0.28

183

841

Missing teeth due to accident, extraction or parodontitis

237

1893

1.18

1.74

1.3

14.67

13.42

u/l

0.53

218

1744

Conjunctivitis (acute, non atopic)

572

1.34

1.74

1.3

16.81

13.53

u/l

0.28

525

Other diseases of urinary system

379

1863

1.14

1.73

1.3

14.72

13.61

u/l

0.41

347

1725

Myalgia

498

1.37

1.73

1.3

1.2

11.03

13.90

u/l

1.62

462

Behavioural syndromes associated with physiological disturbances and physical factors

218

1832

0.84

1.73

1.3

12.81

14.41

u/l

0.70

202

1686

Burns and corrosions of multiple body regions

3.89

1.72

1.0

1.2

15.00

11.23

u/l

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

3.87

1.72

1.2

18.20

10.54

u/l

—

Other and specified injuries of hip and thigh

2.31

1.71

1.3

1.2

11.27

11.37

u/l

0.01

Dermatophytosis

209

1763

1.19

1.64

1.2

1.3

16.26

14.17

u/l

0.52

192

1630

Use of donepezil

849

0.74

1.64

1.3

18.97

13.15

u/l

0.89

767

Other disorders of lacrimal gland

114

906

1.26

1.63

1.2

1.3

10.92

13.10

u/l

1.35

106

833

Explicit fungal Sepsis

3.62

1.62

1.8

1.4

17.60

10.36

u/l

—

Psychiatric diseases

368

1616

1.14

1.61

1.3

14.70

13.78

u/l

0.23

342

1501

Acute and subacute iridocyclitis

462

1.37

1.61

1.2

1.3

13.58

13.32

u/l

0.04

431

Diseases of inner ear

149

1749

0.82

1.61

1.3

12.33

13.64

u/l

0.56

137

1611

Other disorders of veins

132

1063

1.24

1.60

1.2

1.3

15.79

13.69

u/l

0.51

123

976

Anterior Iridocyclitis

497

1.35

1.60

1.3

13.53

13.23

u/l

0.05

460

Injuries involving multiple body regions

2.07

1.60

1.5

1.2

20.77

11.21

u/l

0.31

Umbilical hernia

776

1.28

1.60

1.2

1.3

17.70

14.28

u/l

0.54

720

Chondropathies

280

1.47

1.56

1.4

1.3

16.69

12.37

u/l

0.70

257

Recurrent or chronic depression

564

0.73

1.55

1.2

1.3

13.74

14.48

u/l

0.14

518

Malignant neoplasm of pancreas, including Hilmo

160

1.63

1.55

1.3

1.2

16.57

10.69

u/l

0.67

139

Alcohol abuse, main dg

356

1.41

1.53

1.1

1.3

14.47

14.46

u/l

0.00

331

Soft tissue disorders related to use, overuse and pressure

763

1.27

1.53

1.3

15.39

14.21

u/l

0.10

709

Abdominal aortic aneurysm (AAA)

463

1.35

1.53

1.2

1.3

10.48

15.20

u/l

1.79

424

Presbycusis

574

1.31

1.52

1.4

1.3

13.05

13.66

u/l

0.11

527

Coxarthrosis [arthrosis of hip](FG)

228

1371

1.17

1.52

1.3

12.26

13.54

u/l

0.56

214

1272

Diseases of external ear

119

962

1.24

1.50

1.3

15.91

13.99

u/l

0.21

109

881

Spinal stenosis

230

1497

1.17

1.49

1.3

12.09

13.51

u/l

0.87

209

1387

Prurigo nodularis

2.08

1.49

1.2

15.00

11.80

u/l

0.39

Other anxiety disorders

647

1.27

1.49

1.2

1.3

13.81

13.82

u/l

0.00

601

Symptoms and signs involving the nervous and musculoskeletal systems

209

1783

1.17

1.48

1.3

14.07

13.72

u/l

0.06

187

1646

Superficial injury of ankle and foot

170

1.59

1.48

1.4

1.3

15.44

13.27

u/l

0.20

155

Acute upper respiratory infections

381

2081

1.13

1.48

1.3

13.70

13.79

u/l

0.03

349

1920

Polycystic ovarian syndrome, consortium definition

145

706

1.22

1.45

1.3

1.2

11.99

11.96

u/l

0.01

126

645

Benign neoplasm: Kidney

1.88

1.45

1.5

1.2

16.73

11.21

u/l

0.49

Other misadventures during surgical and medical care

2.13

1.45

1.7

1.3

13.73

11.64

u/l

0.15

Melanoma in situ of upper limb, including shoulder

3.16

1.44

1.0

1.3

11.00

13.62

u/l

—

Malignant neoplasm of pancreas

125

1.69

1.43

1.3

16.94

10.89

u/l

0.51

109

Diseases of pulp and periapical tissues and dental caries

281

1252

1.15

1.43

1.3

12.07

12.68

u/l

0.29

260

1147

Other diseases of hard tissues of teeth

252

1125

1.16

1.43

1.3

13.29

13.28

u/l

0.00

238

1024

Malignant neoplasm of stomach, including Hilmo

118

1.70

1.41

1.3

1.2

11.55

9.41

u/l

0.36

105

Viral warts

157

1.60

1.40

1.3

10.00

12.21

u/l

0.47

145

Disorders of the thyroid gland

339

1953

1.13

1.40

1.3

12.73

14.05

u/l

0.44

314

1800

Disorders of lacrimal system

142

1177

1.20

1.39

1.2

1.3

11.41

13.12

u/l

1.04

128

1078

Complications of internal orthopaedic prosthetic devices, implants and grafts

730

1.26

1.39

1.4

1.3

11.60

13.04

u/l

0.53

670

Malignant neoplasm of stomach

1.78

1.38

1.2

1.3

11.53

9.91

u/l

0.24

Contusion of other and unspecified parts of foot

2.08

1.38

1.3

1.1

9.64

11.73

u/l

0.53

Generalized skin eruption due to drugs and medicaments

1.95

1.38

1.7

1.2

9.31

12.19

u/l

0.53

Gingivitis and periodontal diseases

389

1790

1.12

1.36

1.3

15.82

13.33

u/l

0.97

360

1645

Disorders of refraction and accommodation

466

1.33

1.36

1.3

9.05

12.70

u/l

3.05

434

Delivery, wide proxy

381

0.74

1.36

1.1

1.2

10.54

12.87

u/l

0.92

338

Fracture at wrist and hand level

101

811

1.24

1.35

1.3

14.36

14.47

u/l

0.01

745

Hernia of abdominal wall

173

1468

1.18

1.35

1.3

15.32

13.95

u/l

0.31

156

1354

Other blood glucose lowering drugs, excl. Insulins

521

1.31

1.35

1.4

1.3

11.42

13.10

u/l

0.52

477

Alzheimer disease

125

1108

0.82

1.35

1.2

1.3

24.56

11.94

u/l

1.81

108

1012

Other disorders of Eustachian tube

2.14

1.34

1.4

1.2

10.00

10.90

u/l

—

Dorsalgia

350

1665

1.13

1.33

1.3

13.17

14.28

u/l

0.49

319

1542

Caries of enamel

195

1637

0.86

1.32

1.3

16.07

14.33

u/l

0.34

186

1505

Episodal and paroxysmal disorders

384

1747

1.12

1.30

1.3

14.97

14.12

u/l

0.24

339

1618

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

574

1.28

1.30

1.3

13.22

13.48

u/l

0.06

531

Primary gonarthrosis, bilateral

165

1661

0.85

1.30

1.3

14.08

13.69

u/l

0.10

156

1528

Benign paroxysmal vertigo

851

0.77

1.28

1.5

1.3

11.53

12.76

u/l

0.36

776

Intentional self-harm by sharp object

2.79

1.28

1.2

18.80

9.11

u/l

—

Infections with a predominantly sexual mode of transmission

456

1.31

1.28

1.3

1.2

15.44

13.42

u/l

0.52

424

Melanocytic naevi

667

1.26

1.28

1.3

21.78

12.95

u/l

0.49

615

Nontoxic diffuse goitre

2.01

1.27

1.4

1.1

9.18

10.71

u/l

0.45

Superficial injury of lower leg

526

1.29

1.27

1.4

1.3

9.97

13.06

u/l

1.91

485

Sleep disorders (combined)

410

1935

1.11

1.27

1.3

13.76

14.27

u/l

0.18

379

1785

Adverse effects, not elsewhere classified

336

1.37

1.26

1.3

12.80

12.01

u/l

0.14

311

Varicose veins

240

1583

1.15

1.26

1.3

12.42

13.76

u/l

0.77

217

1469

Acute generalized exanthematous pustulosis

1.82

1.25

1.6

1.2

8.93

11.97

u/l

0.63

severe traumatic brain injury, does not include concussion

101

822

1.23

1.25

1.4

1.3

13.44

14.14

u/l

0.19

748

Juvenile arthritis (FINNGEN)

2.23

1.24

1.6

1.1

14.13

11.52

u/l

—

Impingement syndrome of shoulder

688

1.25

1.24

1.2

1.3

10.47

13.95

u/l

2.33

643

Other specified/unspecified bacterial intestinal infections

139

1.59

1.23

1.5

1.2

12.32

12.37

u/l

0.01

129

Follow-up examination after treatment for conditions other than malignant neoplasms

139

770

1.20

1.23

1.3

1.2

14.42

14.17

u/l

0.03

131

725

Dyshidrosis [pompholyx]

2.64

1.22

1.2

9.20

12.05

u/l

—

Functional dyspepsia

619

1.26

1.21

1.3

12.00

12.55

u/l

0.17

578

Other vitreous opacities

1.75

1.19

1.2

12.60

12.76

u/l

0.02

Exposure to other and unspecified animate mechanical forces

2.31

1.18

1.0

1.2

6.83

11.69

u/l

—

Schizophrenia

289

1.39

1.18

1.2

14.09

13.09

u/l

0.26

270

Demyelinating diseases of the central nervous system

102

1.67

1.16

1.2

35.47

10.88

u/l

0.51

Polymyalgia rheumatica

420

1.31

1.16

1.1

1.3

14.60

12.40

u/l

0.51

383

Urolithiasis

1190

0.82

1.15

1.5

1.3

12.92

14.57

u/l

0.46

1099

Other factor of the environment

2.52

1.15

1.4

1.2

10.20

u/l

—

Carcinoma in situ of other and unspecified genital organs

2.51

1.15

1.4

1.1

15.00

15.87

u/l

—

Ventral hernia

707

1.23

1.12

1.3

12.34

13.11

u/l

0.21

647

Convergent concomitant strabismus

1.90

1.12

1.5

1.1

15.91

11.98

u/l

0.32

Psychotic depression

115

0.43

1.11

1.2

1.3

17.60

11.65

u/l

—

108

Strabismus

554

1.26

1.11

1.3

15.16

12.94

u/l

0.49

512

Alzheimer’s disease, strict definition

958

0.82

1.10

1.2

1.3

25.72

11.95

u/l

1.54

873

Use of selegiline

136

0.51

1.09

1.1

1.3

16.14

12.87

u/l

—

125

Paralytic ileus

104

1.64

1.09

1.4

1.2

36.12

10.68

u/l

0.63

Female genital prolapse

358

0.76

1.09

1.1

1.2

9.00

11.49

u/l

1.23

325

Torticollis

2.39

1.09

2.0

1.2

8.40

8.95

u/l

—

Benign neoplasm of urinary organs

120

1.59

1.08

1.4

1.2

15.53

12.81

u/l

0.25

111

Postmenopausal osteoporosis with pathological fracture

128

1.57

1.08

1.4

1.2

8.73

10.48

u/l

0.38

110

Haemorrhoids and perianal venous thrombosis

122

1027

1.19

1.08

1.2

1.3

13.05

13.66

u/l

0.21

110

960

Fracture of forearm

165

1306

1.16

1.07

1.2

1.3

12.90

12.79

u/l

0.02

145

1206

Polyarthrosis

535

1.25

1.06

1.3

14.74

11.85

u/l

0.84

494

Disorders of vestibular function (Vertigo)

128

1476

0.85

1.04

1.4

1.3

12.45

13.27

u/l

0.28

118

1356

Disorders of muscles

237

1.40

1.04

1.3

16.39

14.40

u/l

0.24

219

Presence of other devices

103

856

1.20

1.04

1.4

1.3

10.88

13.70

u/l

1.92

794

Pregnancy, childbirth and the puerperium

340

0.77

1.03

1.3

1.2

8.59

12.00

u/l

2.39

303

Episcleritis

1.74

1.02

1.6

1.2

12.00

11.15

u/l

0.15

Seborrhoeic keratosis

699

1.22

1.00

1.3

21.52

13.31

u/l

0.42

639

Other and unspecified glaucoma

205

1.42

1.00

1.3

24.17

10.42

u/l

0.67

192

Injuries to the shoulder and upper arm

301

2188

1.11

1.00

1.3

13.99

13.95

u/l

0.01

282

2011

Allergic urticaria

123

1.55

0.99

1.3

1.2

16.21

12.83

u/l

0.37

112

Postprocedural disorders of digestive system, not elsewhere classified

1.72

0.99

1.4

1.2

13.23

12.13

u/l

0.10

Cholecystectomy

256

1978

1.12

0.98

1.3

11.93

13.59

u/l

0.86

231

1831

Acute alcohol intoxication

774

1.20

0.98

1.2

1.3

14.16

14.79

u/l

0.13

712

Benign neoplasm of bone and articular cartilage

140

1.50

0.97

1.4

1.2

28.71

11.54

u/l

1.02

128

Papilloedema, unspecified

0.00

0.96

0.0

1.2

—

12.10

—

Alzheimer’s disease (Late onset)

916

0.83

0.95

1.2

1.3

26.06

12.01

u/l

1.47

835

Acute alcohol intoxication, ICD10

498

1.25

0.93

1.1

1.3

13.79

13.59

u/l

0.04

463

Low back pain

253

1631

1.11

0.92

1.3

13.27

14.16

u/l

0.29

230

1510

Injury of muscle and tendon at shoulder and upper arm level

100

1180

0.85

0.91

1.2

1.3

13.34

13.73

u/l

0.09

1089

Female infertility

235

0.72

0.91

1.1

1.2

12.18

11.90

u/l

0.04

215

Persistent mood disorders

429

1.26

0.89

1.3

13.00

11.89

u/l

0.24

394

Unspecified mental disorder

102

865

1.18

0.89

1.2

1.3

15.48

12.93

u/l

0.66

804

Abnormal serum enzyme levels

141

1196

1.15

0.89

1.3

12.36

14.81

u/l

1.06

120

1114

Myocardial infarction, with ST-elevation

719

1.20

0.89

1.3

11.66

13.96

u/l

0.66

653

Deep bite

113

0.54

0.88

1.1

1.3

21.43

11.70

u/l

—

103

Calculus of kidney and ureter

1067

0.84

0.88

1.5

1.3

11.34

14.14

u/l

1.42

982

Anxiety (asthma-related co-morbidities)

131

876

1.16

0.88

1.2

1.3

13.98

14.70

u/l

0.16

118

817

Carcinoma in situ, bladder

111

1.54

0.88

1.2

1.3

12.06

13.42

u/l

0.17

106

Leiomyoma of uterus

137

672

1.16

0.87

1.2

11.22

11.77

u/l

0.22

124

610

Other maltreatment syndromes

2.00

0.87

1.2

27.17

10.17

u/l

—

Other enthesopathies

721

1.19

0.87

1.4

1.3

14.00

13.87

u/l

0.03

671

Other joint disorders

275

1311

1.11

0.87

1.3

13.92

14.00

u/l

0.02

250

1217

Diseases of salivary glands

767

1.19

0.86

1.3

13.34

12.88

u/l

0.12

705

Migraine

697

0.83

0.86

1.4

1.3

12.25

12.37

u/l

0.03

657

Keratitis

104

889

1.17

0.84

1.3

13.65

13.32

u/l

0.05

819

Erectile dysfunction

344

1.28

0.84

1.2

1.3

10.44

13.16

u/l

0.85

325

Other juvenile arthritis

1.94

0.84

1.8

1.1

15.33

11.50

u/l

—

Inflammatory bowel disease

733

1.19

0.84

1.4

1.3

21.09

12.90

u/l

0.44

680

Use of galantamine

297

0.71

0.83

1.2

1.3

12.29

13.15

u/l

0.10

271

Other disorders of the musculoskeletal system and connective tissue

371

1.27

0.83

1.2

1.3

15.21

13.04

u/l

0.33

341

Ulcerative colitis

560

1.22

0.83

1.4

1.3

12.00

12.57

u/l

0.16

520

Gonarthrosis [arthrosis of knee](FG)

276

1456

1.10

0.83

1.3

13.57

13.53

u/l

0.01

252

1349

Gonarthrosis

243

1248

1.11

0.83

1.3

13.81

13.52

u/l

0.08

222

1160

Coxarthrosis

203

1199

1.12

0.82

1.3

12.41

13.40

u/l

0.38

190

1115

Myocardial infarction, unclassifiable

117

904

1.16

0.81

1.2

1.3

12.53

13.74

u/l

0.23

102

825

Other and unspecified urticaria

338

1.27

0.79

1.3

15.82

11.46

u/l

0.75

313

Femoral hernia, unilateral

1.67

0.79

1.2

15.82

10.55

u/l

0.66

Inguinal of femoral hernia, unilateral

1.67

0.79

1.2

15.82

10.55

u/l

0.66

Inguinal hernia, unilateral

1.67

0.79

1.2

15.82

10.55

u/l

0.66

Other disorders of eyelid

181

1540

1.12

0.79

1.2

1.3

11.39

13.31

u/l

0.97

168

1415

Hypothyroidism, other/unspecified

299

1799

1.09

0.78

1.3

12.70

13.96

u/l

0.35

275

1658

0.00

0.78

0.0

1.1

—

11.15

—

Carcinoma in situ of other and unspecified sites

123

1.47

0.77

1.2

1.3

12.67

12.93

u/l

0.03

116

Symptoms and signs involving speech and voice

109

944

1.16

0.77

1.4

1.3

12.46

13.20

u/l

0.26

100

867

Non-selective monoamine reuptake inhibitors

130

1099

1.14

0.77

1.3

16.82

13.45

u/l

0.46

120

1004

Kela-code for severe mental illness

787

1.17

0.76

1.2

1.3

15.86

13.10

u/l

0.65

730

Cervicobrachial syndrome

517

0.79

0.76

1.4

1.2

10.47

13.14

u/l

0.97

485

Degenerative diseases of the nervous system

148

1227

0.88

0.76

1.2

1.3

22.81

12.15

u/l

1.86

131

1122

Scleritis and episcleritis

1.54

0.75

1.6

1.2

11.86

11.10

u/l

0.14

Other abnormal uterine and vaginal bleeding

347

1.22

0.73

1.4

1.2

11.14

11.56

u/l

0.08

317

Nontoxic multinodular goitre

487

1.21

0.73

1.2

1.3

11.23

12.79

u/l

0.53

443

Benign neoplasm of brain and other parts of central nervous system

134

0.60

0.73

1.0

1.2

20.25

12.30

u/l

—

123

Sexual dysfunction

2.01

0.73

1.0

1.2

11.20

9.20

u/l

—

Mood disorders

281

1979

0.92

0.72

1.2

1.3

15.48

14.06

u/l

0.38

263

1815

Other/unspecified dorsalgia

121

1054

1.14

0.71

1.4

1.3

14.74

13.81

u/l

0.19

114

977

Any dementia

165

1279

0.89

0.71

1.2

1.3

20.79

12.34

u/l

1.47

143

1174

Hypothyreosis and Thyroxine purchase for inclusion criteria

310

1875

1.08

0.71

1.3

12.51

13.78

u/l

0.37

286

1728

Encephalopathy

1.94

0.71

1.0

1.3

11.80

10.62

u/l

—

Mood [affective] disorders

280

1973

0.92

0.70

1.2

1.3

15.49

14.08

u/l

0.38

262

1809

Otosclerosis

182

0.66

0.70

1.3

13.75

11.78

u/l

0.27

170

Disorders of synovium and tendon

130

1285

0.89

0.70

1.4

1.3

13.16

14.52

u/l

0.45

116

1186

Diseases of male genital organs

215

983

1.10

0.69

1.4

1.3

15.07

15.16

u/l

0.01

202

917

Noninflammatory disorders of female genital tract

373

0.83

0.68

1.2

12.49

11.96

u/l

0.12

340

Colectomy operation

538

1.19

0.67

1.2

1.3

10.75

12.31

u/l

0.58

492

Other disorders of urethra and urinary system

246

1627

1.09

0.67

1.3

14.71

13.54

u/l

0.37

220

1510

Female infertility, cervical, vaginal, other or unspecified origin

230

0.76

0.67

1.1

1.2

13.00

11.83

u/l

0.20

210

Viral infections of the central nervous system

119

1.43

0.66

1.1

1.2

12.12

11.42

u/l

0.08

106

All anxiety disorders

131

919

1.13

0.66

1.2

1.3

13.98

14.64

u/l

0.15

118

850

Rotator cuff syndrome

226

1482

1.09

0.65

1.3

14.18

14.43

u/l

0.07

200

1375

Vertigo of central origin

1.60

0.65

1.1

13.14

12.26

u/l

—

Gestational diabetes (for exclusion)

173

0.72

0.64

1.3

1.2

14.33

13.87

u/l

0.05

163

Arthrosis

252

1270

1.09

0.64

1.3

13.72

13.67

u/l

0.01

229

1179

Injury of muscle and tendon at lower leg level

403

0.79

0.62

1.3

12.78

13.68

u/l

0.17

376

All dysplastic lesions of the cervix uteri, vagina or vulva

266

1.26

0.62

1.1

1.2

11.90

11.48

u/l

0.08

243

Prolonged pregnancy

1.52

0.61

1.2

19.83

12.94

u/l

0.88

Paranoid personality disorder

1.67

0.61

1.4

1.2

18.00

10.83

u/l

—

Viral infections of the central nervous system

130

1.39

0.61

1.1

1.2

11.72

12.96

u/l

0.15

116

Lateral epicondylitis

253

1.27

0.60

1.3

15.93

12.90

u/l

0.47

237

Carcinoma in situ of skin, other sites/unspecified

1.58

0.60

1.3

15.88

12.14

u/l

—

Complications of genitourinary prosthetic devices, implants and grafts

1.57

0.60

1.3

1.2

11.13

17.20

u/l

—

Urticaria

545

1.17

0.60

1.3

16.07

13.10

u/l

0.61

506

Human immunodeficiency virus [HIV] disease

0.00

0.60

0.0

1.1

—

9.48

—

MS-disease / Multiple Sclerosis

1.50

0.59

1.3

1.2

12.25

11.20

u/l

0.16

Crushed, pushed or stepped on by crowd or human stampede

1.50

0.59

1.3

1.2

16.08

11.29

u/l

0.94

Memory loss

290

1.24

0.59

1.4

1.3

16.06

11.94

u/l

0.54

267

Endometriosis of pelvic peritoneum

199

0.72

0.58

1.3

1.2

21.47

12.33

u/l

1.23

182

Benign neoplasm of other and unspecified sites

1.57

0.58

1.2

21.20

11.25

u/l

—

Carcinoma in situ of colon

1.52

0.58

1.1

1.2

42.75

11.42

u/l

—

Oxicams

535

0.87

0.58

1.2

1.3

11.84

14.66

u/l

0.72

483

Oral lichen planus, including avohilmo , including avohilmo

113

0.62

0.58

1.7

1.2

10.14

10.38

u/l

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

697

1.15

0.57

1.4

1.3

14.55

14.27

u/l

0.04

646

Glucagon-like peptide-1 (GLP-1) analogues

697

1.15

0.57

1.4

1.3

14.55

14.27

u/l

0.04

646

Other congenital malformations of the digestive system

1.52

0.57

1.2

8.00

11.20

u/l

1.09

Tuberculosis of other organs

1.49

0.57

1.4

1.2

16.50

15.63

u/l

—

Benign neoplasm: Skin of lower limb, including hip

1.49

0.57

1.8

1.2

7.38

12.15

u/l

—

Cluster headache, strict, including avohilmo

1.48

0.57

1.1

13.88

10.37

u/l

—

Visual disturbances and blindness

170

1552

1.10

0.55

1.2

1.3

10.85

13.92

u/l

2.75

151

1430

Chronic sinusitis

123

1104

1.11

0.55

1.4

1.3

15.35

14.26

u/l

0.14

118

1018

Crohn's disease of large intestine

1.54

0.55

1.2

10.20

9.88

u/l

—

Other specific joint derangements/joint disorders

207

1230

1.09

0.55

1.4

1.3

15.18

13.95

u/l

0.36

190

1141

Fall on same level involving ice and snow

177

1621

1.09

0.55

1.3

12.94

13.86

u/l

0.38

157

1496

Periapical abscess

129

1164

1.11

0.54

1.3

12.37

14.43

u/l

1.03

122

1077

Other orthopaedic follow-up care

1.47

0.54

1.2

12.17

10.03

u/l

0.39

Migraine without aura

186

1.29

0.54

1.4

1.2

15.71

11.10

u/l

1.26

177

Other congenital malformations of the digestive system

1.47

0.53

1.1

1.2

6.33

10.82

u/l

—

Chronic rhinitis, nasopharyngitis and pharyngitis

740

1.14

0.53

1.3

14.41

13.40

u/l

0.30

684

Alzheimer disease, excluding more controls

516

0.87

0.52

1.2

1.3

32.00

12.15

u/l

1.54

486

Other degenerative diseases of the nervous system

109

728

1.12

0.52

1.1

1.3

28.30

12.27

u/l

1.76

100

689

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

1.52

0.52

1.3

1.2

8.00

12.66

u/l

—

Organic, including symptomatic, mental disorders

234

1545

1.08

0.52

1.2

1.3

18.21

12.27

u/l

1.46

210

1434

Other erythematous conditions

1.43

0.52

1.1

8.33

11.48

u/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

117

1028

0.90

0.52

1.3

10.33

13.48

u/l

2.77

110

948

Any dementia, excluding more controls

152

1146

0.91

0.51

1.2

1.3

20.23

12.43

u/l

1.20

133

1058

Combinations of oral blood glucose lowering drugs

104

931

1.12

0.51

1.3

10.04

14.77

u/l

4.16

859

Tuberculosis of other organs, strict

1.41

0.51

1.3

1.2

16.33

14.93

u/l

—

Alzheimer’s disease (Late onset), excluding more controls

463

0.86

0.51

1.2

1.3

31.61

12.21

u/l

1.37

434

Hypothyroidism, strict autoimmune, 3 medication purchases required

271

1710

1.07

0.50

1.3

13.07

13.79

u/l

0.17

256

1575

Adenocarcinoma and papillary adenocarcinoma of stomach

1.47

0.50

1.2

12.33

10.19

u/l

—

Amenorrhoea

1.56

0.49

1.1

1.2

9.14

10.00

u/l

—

Type 1 diabetes, strict (exclude DM2)

1.43

0.48

1.0

1.2

9.00

15.29

u/l

1.12

Type 1 diabetes, definitions combined

1.43

0.48

1.0

1.1

9.00

15.26

u/l

1.11

Coxibs

115

545

1.11

0.48

1.3

12.33

15.03

u/l

0.70

107

492

Nontraumatic intracranial haemmorrhage

718

1.13

0.48

1.3

10.76

14.25

u/l

1.60

662

Single spontaneous delivery

423

0.88

0.48

1.2

10.25

13.22

u/l

1.47

380

Polyuria

747

1.13

0.47

1.4

1.3

14.25

13.84

u/l

0.08

681

Neuralgia and neuritis, unspecified

102

1.37

0.47

1.2

13.29

9.94

u/l

0.60

Complications following abortion and ectopic and molar pregnancy

1.46

0.47

1.7

1.2

9.14

11.26

u/l

—

Coxarthrosis, primary, with hip surgery

172

1740

0.92

0.46

1.4

1.3

12.54

13.48

u/l

0.33

161

1603

Follow-up care involving plastic surgery

1.43

0.46

1.3

1.2

9.00

9.74

u/l

—

Viral warts

393

1.17

0.45

1.3

12.41

12.17

u/l

0.04

365

Fenamates

306

0.84

0.45

1.5

1.3

12.03

13.29

u/l

0.21

272

Suppurative and unspecified otitis media

523

1.14

0.44

1.3

12.24

14.20

u/l

0.62

483

Anxiety disorders, excluding more controls

231

1406

1.07

0.43

1.3

12.91

13.88

u/l

0.40

211

1293

Blepharochalasis

104

943

1.10

0.43

1.2

1.3

11.26

12.93

u/l

0.52

859

Appendectomy

166

1470

1.08

0.43

1.4

1.3

12.76

14.74

u/l

0.67

160

1356

Headache

153

1128

1.08

0.42

1.3

13.13

13.98

u/l

0.24

141

1055

Endometriosis ASRM stages 1,2

196

0.76

0.42

1.3

1.2

21.47

10.85

u/l

1.54

178

Transport accidents

124

977

1.09

0.42

1.3

21.43

14.65

u/l

0.74

115

910

Benign neoplasm: Eye, unspecified

0.00

0.41

0.0

1.3

—

10.07

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.52

0.41

1.2

36.20

13.00

u/l

—

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.41

0.0

1.4

—

13.80

—

Specific development disorders of scholastic skills

0.00

0.41

0.0

1.3

—

16.13

—

Premature separation of placenta [abruptio placentae]

0.00

0.41

0.0

1.1

—

11.73

—

Benign neoplasm: Skin of ear and external auricular canal

105

1.34

0.41

1.4

1.2

10.07

13.56

u/l

0.42

Frostbite

0.00

0.40

0.0

1.1

—

9.76

—

Causalgia

0.00

0.40

0.0

1.2

—

6.94

—

Neuromuscular dysfunction of bladder

259

1.20

0.40

1.1

1.3

16.46

13.51

u/l

0.40

237

Injury of muscle and tendon at hip and thigh level

195

1.23

0.40

1.7

1.3

9.92

12.05

u/l

0.61

179

Peripheral retinal degeneration

1.34

0.40

1.4

1.2

10.38

14.47

u/l

—

Melanocytic naevi of eyelid, including canthus

0.00

0.40

0.0

1.1

—

12.94

—

Patellar tendinitis

0.00

0.40

0.0

1.3

—

8.89

—

Mixed hyperlipidaemia

102

0.68

0.39

1.1

1.2

6.43

12.16

u/l

—

Uterine polyps

171

0.76

0.39

1.3

1.2

8.38

12.25

u/l

1.02

155

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.00

0.39

0.0

1.1

—

9.37

—

Pregnancy hypertension

444

0.87

0.38

1.3

1.2

14.03

12.35

u/l

0.46

408

Glaucoma

229

1856

1.06

0.38

1.3

15.83

13.12

u/l

0.60

208

1714

Atrophic disorders of skin

269

0.82

0.38

1.7

1.2

10.64

11.62

u/l

0.18

244

Menorrhagia

368

1.12

0.37

1.4

1.2

11.16

11.59

u/l

0.10

335

Other disorders of choroid

1.35

0.37

1.2

9.80

11.09

u/l

—

Benign neoplasm: Pancreas

1.39

0.37

1.2

8.70

12.69

u/l

—

Delivery

423

0.90

0.36

1.2

10.30

13.22

u/l

1.46

380

Depression

252

1803

0.95

0.36

1.2

1.3

13.59

14.02

u/l

0.16

236

1652

Cystitis

266

1668

0.95

0.36

1.3

13.65

13.55

u/l

0.03

248

1549

Dislocation, sprain and strain of joints and ligaments of knee

125

1244

0.93

0.36

1.2

1.3

13.13

14.76

u/l

0.64

112

1162

Pain in joint

181

1082

1.07

0.35

1.4

1.3

15.98

14.79

u/l

0.28

166

1008

Myasthenia gravis

1.40

0.35

1.3

1.2

9.33

11.47

u/l

—

Acetic acid derivatives and related substances

114

545

1.09

0.34

1.3

16.23

15.03

u/l

0.16

105

492

Autonomic disorders

1.37

0.34

1.3

1.2

10.00

11.29

u/l

—

Other diseases of upper respiratory tract

398

1988

1.04

0.34

1.3

12.71

13.84

u/l

0.48

369

1835

Redundant prepuce, phimosis and paraphimosis

598

1.11

0.34

1.4

1.2

17.11

15.19

u/l

0.24

557

Excessive attrition of teeth

120

1292

0.93

0.33

1.3

13.93

15.03

u/l

0.26

110

1198

Vasomotor and allergic rhinitis

706

0.90

0.33

1.3

1.2

12.76

13.68

u/l

0.16

648

Other bursopathies

359

1.14

0.33

1.4

1.2

14.74

13.54

u/l

0.18

333

Diseases of middle ear and mastoid

136

1037

1.07

0.33

1.3

12.13

14.18

u/l

1.09

127

952

Sciatica+with lumbago

138

1358

0.93

0.32

1.3

12.14

14.32

u/l

1.05

124

1251

Visual field defects

229

1.18

0.32

1.3

10.24

13.93

u/l

1.07

210

Other acquired deformities of musculoskeletal system and connective tissue

1.33

0.32

1.3

1.2

14.82

10.88

u/l

0.92

Lichen sclerosus et atrophicus

187

0.80

0.32

1.9

1.2

10.47

10.52

u/l

0.01

166

Pain and other conditions associated with female genital organs and menstrual cycle

212

0.82

0.32

1.2

13.32

12.91

u/l

0.04

194

Femoral hernia

119

1.26

0.31

1.3

13.47

12.67

u/l

0.08

109

Postpartum hemorraghe, parous women as controls

132

1.23

0.31

1.2

14.68

12.66

u/l

0.33

122

Gonarthrosis,primary

321

2064

0.96

0.31

1.3

12.91

14.08

u/l

0.59

296

1900

Effects of foreign body entering through natural orifice

622

0.90

0.31

1.2

1.3

12.39

13.34

u/l

0.32

579

Disorders of conjunctiva

208

1759

0.95

0.30

1.3

15.36

14.32

u/l

0.20

192

1613

Endometriosis of rectovaginal septum and vagina

131

0.76

0.30

1.0

1.2

12.60

11.68

u/l

—

119

Medical treatment for female infertility

130

0.76

0.30

1.2

17.50

12.50

u/l

—

123

Cervical disc disorders

106

1140

0.93

0.30

1.3

1.2

12.43

14.13

u/l

0.66

1051

Other/unspecified synovitis and tenosynovitis

261

0.84

0.30

1.2

11.95

12.38

u/l

0.09

240

Nonsuppurative otitis media

313

1.13

0.30

1.2

1.3

13.39

14.95

u/l

0.26

287

Open wound of wrist and hand

125

1142

1.07

0.30

1.3

16.37

15.31

u/l

0.12

119

1052

Oral leukoplakia, including avohilmo

1.27

0.30

1.3

1.2

16.29

11.42

u/l

—

Subjective visual disturbances

620

1.10

0.29

1.3

10.73

12.65

u/l

0.65

575

Cholesteatoma of middle ear

152

0.79

0.29

1.2

11.58

12.36

u/l

0.11

139

Inflammatory disease of uterus

152

0.79

0.29

1.0

1.2

8.50

11.10

u/l

0.58

135

Injuries to the wrist and hand

313

2080

1.04

0.29

1.3

14.42

14.18

u/l

0.05

287

1922

Arthropod-borne viral fevers and viral haemorrhagic fevers

213

1.17

0.29

1.1

1.3

14.60

12.46

u/l

0.21

196

Endometriosis diagnosis and infertility diagnosis occurring together

1.29

0.28

1.1

1.2

13.55

12.45

u/l

0.12

Neurotic, stress-related and somatoform disorders

232

1549

1.05

0.27

1.3

13.13

14.44

u/l

0.57

211

1430

Left hemicolectomy

1.23

0.27

1.4

1.2

7.75

13.91

u/l

—

Cluster headache, wide,, including avohilmo

1.23

0.27

1.1

1.2

13.88

10.69

u/l

—

Inflammatory diseases of prostate (prostatitis)

480

1.11

0.27

1.4

1.3

10.54

13.26

u/l

1.30

445

Other diseases of gallbladder

104

1.25

0.26

1.5

1.1

9.62

12.16

u/l

0.45

Other and unspecified iridocyclitis

0.69

0.26

1.2

19.20

10.75

u/l

—

Other diseases of lip and oral mucosa

109

1022

1.07

0.26

1.3

19.03

12.53

u/l

2.37

101

944

Chronic mastoiditis

1.25

0.25

1.2

13.78

13.62

u/l

—

Benign neoplasm: Anus and anal canal

1.25

0.25

1.4

1.2

14.22

11.11

u/l

—

Other intervertebral disc disorders

283

1638

1.04

0.25

1.3

13.52

14.08

u/l

0.18

252

1516

Simple and mucopurulent chronic bronchitis

114

1.23

0.25

1.9

1.3

17.50

13.10

u/l

0.34

108

Other disorders of amniotic fluid and membranes

1.20

0.25

1.2

11.67

12.28

u/l

—

Monoarthritis, not elsewhere classified

1.19

0.24

1.4

1.3

15.11

10.14

u/l

—

Nontoxic single thyroid nodule

148

0.81

0.24

1.4

1.3

9.00

10.80

u/l

0.45

137

Dislocation, sprain and strain of joint and ligaments of hip

0.74

0.24

1.2

1.3

8.00

13.33

u/l

—

Other fall from one level to another

561

1.09

0.23

1.4

1.3

16.00

13.40

u/l

0.25

520

Glaucoma suspect

113

1198

0.94

0.23

1.3

16.18

12.82

u/l

0.39

100

1095

Pedestrian injured in transport accident

136

0.81

0.23

1.5

1.2

32.64

11.23

u/l

0.61

125

Endometriosis

364

0.92

0.23

1.4

1.2

16.94

11.69

u/l

1.58

332

Deep endometriosis

125

0.80

0.23

1.0

1.3

12.60

9.83

u/l

—

109

Spondylosis

194

1514

1.04

0.22

1.3

13.05

14.06

u/l

0.41

183

1401

Sixth [abducent] nerve palsy

1.25

0.22

1.2

15.45

12.75

u/l

0.27

Glucosamine medication

173

1444

0.96

0.22

1.4

1.3

12.84

12.94

u/l

0.02

164

1321

Disorders of vitreous body

155

1569

0.95

0.22

1.3

12.58

13.75

u/l

0.52

145

1439

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

1.27

0.22

1.3

8.00

11.77

u/l

—

Idiopathic peripheral autonomic neuropathy

0.00

0.21

0.0

1.3

—

10.09

—

Adrenogenital disorders

0.00

0.21

0.0

1.3

—

10.09

—

Drowning and submersion while in natural water

0.00

0.21

0.0

1.1

—

14.50

—

Factitial dermatitis

0.00

0.21

0.0

1.2

—

16.82

—

Other rupture of muscle

0.00

0.21

0.0

1.3

—

9.09

—

Disorder of pancreatic internal secretion, other and/or unspecified

0.00

0.21

0.0

1.4

—

12.82

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.21

0.0

1.3

—

10.00

—

Lesion of ulnar nerve

353

1.11

0.21

1.5

1.3

11.68

13.96

u/l

0.63

329

Unspecified human immunodeficiency virus [HIV] disease

0.00

0.21

0.0

1.1

—

11.00

—

Thyrotropin deficiency

0.00

0.21

0.0

1.4

—

9.64

—

Striae atrophicae

0.00

0.21

0.0

1.3

—

10.00

—

Overjet

0.00

0.21

0.0

1.2

—

12.10

—

LSIL lesion of the vagina

0.00

0.21

0.0

1.0

—

16.40

—

Mandibular prognathia

0.00

0.21

0.0

1.3

—

11.09

—

Infliximab

0.00

0.21

0.0

1.1

—

9.30

—

Hallux valgus (acquired)

659

0.94

0.21

1.3

13.06

12.18

u/l

0.21

607

Senile degeneration of the brain, not elsewhere classified

0.00

0.21

0.0

1.2

—

11.33

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

0.21

0.0

1.3

—

10.33

—

Bus occupant injured in other and unspecified transport accidents

0.00

0.21

0.0

1.3

—

11.67

—

Vitamin B12 deficiency anaemia

315

1.11

0.21

1.5

1.3

8.66

12.50

u/l

1.89

292

Frontotemporal dementia

0.00

0.21

0.0

1.2

—

14.23

—

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.21

0.0

1.3

—

15.15

—

Donors of organs and tissues

0.00

0.21

0.0

1.2

—

10.85

—

Excessive, frequent and irregular menstruation

372

0.93

0.20

1.3

1.2

11.13

11.76

u/l

0.15

339

Disorders of other and unspecified cranial nerves

0.00

0.20

0.0

1.3

—

9.00

—

Other congenital malformations of upper alimentary tract

0.00

0.20

0.0

1.2

—

12.57

—

Motor neuron disease

1.25

0.20

1.2

1.3

5.50

13.93

u/l

—

Excessive earwax

192

1802

1.04

0.20

1.3

12.39

13.65

u/l

0.54

178

1662

Motor neuron disease (with DMD)

1.20

0.19

1.2

1.3

5.50

13.82

u/l

—

Paraplegia, diplegia of upper limbs

1.18

0.19

1.2

1.3

10.67

11.00

u/l

—

Other dorsopathies, not elsewhere classified

328

1666

1.03

0.19

1.3

13.46

14.28

u/l

0.33

296

1542

Voice disturbances

685

1.07

0.19

1.4

1.3

12.38

12.60

u/l

0.06

629

Striking against or struck by other objects

753

1.06

0.18

1.3

17.57

13.18

u/l

0.83

699

Systemic atrophies primarily affecting the central nervous system

109

1.19

0.18

1.2

8.77

13.67

u/l

0.84

100

Lumbar disc prolapse

189

1504

0.96

0.18

1.3

12.86

14.15

u/l

0.50

171

1390

Progressive vascular leukoencephalopathy

132

0.83

0.18

1.2

1.3

13.09

16.35

u/l

0.24

121

Vertical strabismus

1.19

0.18

1.1

1.2

22.00

10.96

u/l

—

Other and unspecified erythematous conditions

1.17

0.17

1.1

1.2

8.57

11.68

u/l

—

Scar conditions and fibrosis of skin

1.15

0.17

1.3

1.1

11.00

11.45

u/l

—

Primary open-angle glaucoma, strict

104

988

1.05

0.17

1.3

16.08

12.46

u/l

0.42

895

Other disorders of breast

176

1.14

0.17

1.2

9.95

11.01

u/l

0.18

158

Other symptoms and signs involving the nervous and musculoskeletal systems

118

1128

1.05

0.17

1.3

15.77

13.70

u/l

0.22

104

1040

Retinoschisis and retinal cysts

1.11

0.17

1.3

1.2

13.00

11.16

u/l

—

Anxiety disorders

234

1580

1.03

0.17

1.3

13.09

14.39

u/l

0.57

213

1457

Disorders of breast

749

1.05

0.17

1.2

1.3

12.35

11.72

u/l

0.22

680

Other diseases of spinal cord

1.18

0.16

1.3

1.2

16.75

11.49

u/l

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

320

0.92

0.16

1.2

1.3

24.70

12.23

u/l

0.54

301

Necrosis of pulp, including avohilmo

130

1348

0.96

0.15

1.3

16.90

14.58

u/l

0.46

122

1249

Total colectomy operation

0.76

0.15

1.0

1.2

17.00

11.28

u/l

—

Total colectomy

0.76

0.15

1.0

1.2

17.00

11.28

u/l

—

Postprocedural disorders of nervous system

1.15

0.15

1.1

1.2

17.44

11.59

u/l

—

Special screening examination for infectious and parasitic diseases

244

1.09

0.15

1.1

1.2

18.14

16.10

u/l

0.29

232

Nontoxic goitre/thyroid nodule

751

1.05

0.15

1.2

1.3

10.75

12.26

u/l

0.76

686

Cervicocranial syndrome

234

0.90

0.15

1.5

1.3

14.52

11.39

u/l

0.53

219

Alzheimer’s disease (Atypical or mixed)

417

0.93

0.15

1.2

1.3

24.03

12.39

u/l

0.51

377

Internal derangement of knee

109

1040

1.04

0.15

1.3

1.2

12.81

14.04

u/l

0.25

962

Other obstructive and reflux uropathy

1.10

0.15

1.4

1.2

10.78

13.64

u/l

—

Hordeolum and other deep inflammation of eyelid

0.80

0.14

1.3

1.2

13.29

11.66

u/l

—

Infections of genitourinary tract in pregnancy

1.18

0.14

1.5

1.2

9.45

11.75

u/l

0.52

Foreign body entering into or through eye or natural orifice

150

1.13

0.14

1.4

1.3

12.42

12.67

u/l

0.03

140

Meniscus derangement

185

1208

1.03

0.14

1.2

1.3

11.78

13.54

u/l

1.16

172

1121

Artrosis, including avohilmo

285

1598

0.98

0.14

1.3

13.94

14.25

u/l

0.08

265

1470

Selective serotonin reuptake inhibitors

330

1761

0.98

0.13

1.2

1.3

16.55

13.90

u/l

0.86

308

1623

Use of ropinirole

0.82

0.13

1.4

1.2

15.37

11.58

u/l

—

Other/unspecified disorders of vestibular function

0.83

0.13

1.4

1.2

6.13

11.53

u/l

—

Primary hyperparathyroidism

247

1.09

0.13

1.1

1.3

12.86

10.92

u/l

0.21

224

Diseases of the ear and mastoid process

375

1844

1.02

0.13

1.3

13.85

14.25

u/l

0.10

343

1714

Personal history of malignant neoplasm

117

0.85

0.13

1.5

1.2

11.10

10.33

u/l

—

109

Primary coxarthrosis, bilateral

103

1070

0.96

0.13

1.3

13.82

13.06

u/l

0.16

974

Postpartum hemorraghe, all women as controls

168

1.11

0.12

1.2

14.68

14.17

u/l

0.07

154

Maternal care for other conditions predominantly related to pregnancy

135

0.87

0.12

1.3

1.2

12.50

13.70

u/l

0.15

125

Lesion of sciatic nerve

148

0.88

0.12

1.2

18.08

11.03

u/l

0.85

137

Conjunctivitis

174

1494

0.97

0.12

1.3

15.86

13.68

u/l

0.43

163

1369

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

570

1.05

0.12

1.2

1.3

11.58

13.58

u/l

0.82

530

Carpal tunnel syndrome

173

1566

0.97

0.12

1.4

1.3

11.79

14.02

u/l

1.53

159

1448

Lower back pain or/and sciatica

342

2191

1.02

0.11

1.3

13.15

14.04

u/l

0.38

312

2024

Mood disorders, excluding more controls

276

1682

0.98

0.11

1.2

1.3

15.47

13.72

u/l

0.50

258

1556

Primary open-angle glaucoma

130

1219

1.03

0.11

1.3

16.73

12.51

u/l

0.61

121

1113

Extrapyramidal and movement disorders

127

1309

0.97

0.11

1.3

13.06

13.94

u/l

0.32

115

1203

Postpartum haemorrhage

145

1.10

0.11

1.2

14.68

13.98

u/l

0.09

133

Pregnancy with abortive outcome

125

633

1.03

0.10

1.3

1.2

11.29

11.73

u/l

0.15

115

576

D07AA Corticosteroids, weak (group I)

251

1.07

0.09

1.2

1.3

12.81

12.09

u/l

0.16

233

Foreign body or object entering through skin

106

1.13

0.09

1.2

1.3

14.08

11.40

u/l

0.70

100

Diabetes mellitus in pregnancy

133

0.91

0.09

1.3

1.2

12.79

12.90

u/l

0.01

124

conjunctival degenerations and deposits

1.09

0.09

1.4

1.2

10.20

11.17

u/l

—

Anti-inflammatory and antirheumatic products, non-steroids

112

546

1.03

0.09

1.2

1.3

13.12

15.04

u/l

0.34

103

493

Persons encountering health services in circumstances related to reproduction

100

695

0.97

0.09

1.2

21.36

13.77

u/l

0.50

643

Deviated nasal septum

105

1018

1.03

0.09

1.4

1.3

15.06

14.22

u/l

0.15

944

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.04

0.09

1.0

1.1

13.80

11.71

u/l

—

Abnormal involuntary movements

340

1.06

0.09

1.3

10.93

13.45

u/l

0.75

310

Other disorders of eye and adnexa

268

0.93

0.09

1.2

1.3

12.05

11.19

u/l

0.14

248

Depression or dysthymia

225

1219

1.02

0.08

1.3

12.72

13.74

u/l

0.45

214

1129

Radiculopathy

528

1.04

0.08

1.2

13.98

14.00

u/l

0.00

489

Excessive vomiting in pregnancy

0.82

0.08

1.4

1.3

10.20

12.60

u/l

—

Anorexia (incl.atypical)

0.81

0.08

1.2

8.60

12.65

u/l

—

Pedestrian injured in collision with pedal cycle

0.79

0.08

1.6

1.1

12.00

10.86

u/l

—

Other peripheral vertigo

236

0.93

0.08

1.3

15.68

11.72

u/l

0.43

218

Benign neoplasm: other/unspecified salivary gland

1.08

0.08

1.4

1.2

13.57

14.49

u/l

—

Vascular dementia (mixed)

0.84

0.07

1.0

1.3

9.00

14.11

u/l

—

Disturbances of smell and taste

0.81

0.07

1.2

1.1

7.17

9.76

u/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

174

0.92

0.07

1.3

9.81

12.04

u/l

0.51

158

Adhesive capsulitis of shoulder

451

1.04

0.07

1.2

1.3

15.52

13.47

u/l

0.35

419

Diseases of appendix

203

1860

0.98

0.07

1.4

1.3

12.58

14.73

u/l

0.96

195

1710

Bicipital tendinitis

0.89

0.06

1.1

1.3

13.75

12.08

u/l

—

Dementia due to Parkinson's disease

0.85

0.06

1.3

1.2

9.13

13.06

u/l

—

Pterygium

0.85

0.06

1.0

1.2

25.75

13.07

u/l

—

Speech therapy

739

1.03

0.06

1.5

1.3

14.10

12.78

u/l

0.23

674

Diplopia

344

1.05

0.06

1.1

1.3

12.70

13.12

u/l

0.07

316

Eating disorders

1.12

0.06

1.1

1.2

10.90

12.45

u/l

—

Complications of labour and delivery

526

1.03

0.06

1.2

1.3

13.96

12.19

u/l

0.50

483

Spontaneous abortion

438

0.97

0.06

1.2

15.20

12.13

u/l

0.44

404

Ovarian cyst

369

0.97

0.06

1.2

9.31

11.74

u/l

1.40

336

Impacted cerumen

296

1.05

0.05

1.6

1.3

11.39

13.17

u/l

0.41

270

Appendicitis, broad definition

202

1851

0.99

0.05

1.4

1.3

12.64

14.76

u/l

0.94

194

1702

Visual disturbances

141

1387

1.02

0.05

1.3

11.02

13.87

u/l

2.06

125

1282

Pedal cyclist injured in noncollision transport accidents

202

0.94

0.05

1.3

34.84

12.23

u/l

0.53

187

Irregular menses

453

1.03

0.05

1.4

1.2

12.06

12.76

u/l

0.21

419

Superficial injury of shoulder and upper arm

252

0.95

0.05

1.5

1.3

16.04

11.99

u/l

0.48

231

Unspecified dementia

428

1.03

0.04

1.2

1.3

14.83

12.54

u/l

0.32

391

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

500

1.03

0.04

1.3

1.2

12.39

12.54

u/l

0.04

462

Struck by thrown, projected or falling objec

1.10

0.04

1.4

1.3

15.30

10.99

u/l

—

Chalazion

251

0.96

0.04

1.5

1.3

11.75

12.26

u/l

0.08

230

Dystonia

101

1.09

0.04

1.4

1.2

7.91

12.74

u/l

0.86

Coxarthrosis, primary

231

1974

0.99

0.04

1.3

12.13

13.51

u/l

0.71

216

1816

Mouth breathing

111

1123

0.99

0.03

1.3

13.94

14.22

u/l

0.07

103

1041

Flat foot [pes planus] (acquired)

191

1.05

0.03

1.2

1.3

16.58

11.32

u/l

0.55

174

Inflammatory diseases of female pelvic organs

100

745

0.99

0.03

1.3

13.19

11.86

u/l

0.40

679

Other/unspecified enthesopathies, not elsewhere classified

211

1.04

0.03

1.4

1.3

12.94

13.80

u/l

0.11

193

Tooth eruption problems

100

1.07

0.02

1.3

1.2

24.64

14.27

u/l

0.29

Calculus of lower urinary tract

188

0.96

0.02

1.2

1.3

17.17

14.59

u/l

0.16

176

Spirochaetal infections, other/unspecified

198

0.96

0.02

1.2

1.3

13.74

12.02

u/l

0.23

181

Disorders of vitreous body and globe

166

1606

0.99

0.02

1.3

12.37

13.70

u/l

0.67

155

1471

Migraine without aura and triptan purchases

133

1.05

0.01

1.4

1.2

13.43

11.69

u/l

0.35

121

Other disorders of cornea

217

0.97

0.01

1.2

1.3

12.05

11.33

u/l

0.06

202

Non-allergic asthma

193

1.04

0.01

1.3

9.87

11.80

u/l

0.45

179

Artificial joint operation, meniscal resection

327

2115

1.00

0.01

1.3

12.28

14.08

u/l

1.56

298

1954

Other noninflammatory disorders of uterus, except cervix

345

1.02

0.01

1.2

10.74

11.57

u/l

0.21

314

Other disorders of conjunctiva

413

1.02

0.01

1.5

1.3

12.81

12.64

u/l

0.02

379

Herpesviral keratitis and keratoconjunctivitis

1.06

0.01

1.3

1.2

29.00

13.82

u/l

—

Dorsopathies

327

1666

1.00

0.00

1.3

13.59

14.28

u/l

0.28

294

1542

Medical abortion

115

620

1.01

0.00

1.3

1.2

10.43

11.81

u/l

0.76

107

565

Other arthrosis

170

1178

1.00

0.00

1.3

12.81

13.53

u/l

0.21

156

1092

Other extrapyramidal and movement disorders in other diseases

693

1.00

0.00

1.3

14.47

13.09

u/l

0.33

634

Laparoscopic right hemicolectomy

165

1.03

0.00

1.2

9.47

12.23

u/l

1.00

151

Wet age-related macular degeneration

703

0.99

0.00

1.2

1.3

12.32

12.99

u/l

0.18

634

Melanocytic naevi of other and unspecified parts of face

1.01

0.00

1.6

1.2

14.60

10.40

u/l

—

Undefined dementia

453

1.00

0.00

1.2

1.3

14.82

13.42

u/l

0.17

411

Vasomotor rhinitis (mode)

151

0.99

0.00

1.5

1.3

11.00

11.81

u/l

0.12

136

Other disorders of nervous system

159

1.01

0.00

1.6

1.3

14.56

11.94

u/l

0.33

146

Acute appendicitis

189

1763

1.00

0.00

1.4

1.3

12.93

14.91

u/l

0.78

182

1620

Allergic rhinitis

427

1.00

0.00

1.2

1.3

13.32

12.86

u/l

0.05

395

Spontaneous rupture of synovium and tendon

198

1.01

0.00

1.2

1.3

16.70

12.28

u/l

0.66

181

Early lumbar disc prolapse, operated

1.01

0.00

1.2

21.80

12.67

u/l

—

Other noninflammatory disorders of vagina

127

1.02

0.00

1.7

1.2

7.23

10.38

u/l

1.50

115

Stenosis and insufficiency of lacrimal passages

233

0.99

0.00

1.3

12.94

11.17

u/l

0.24

212

Carcinoma in situ of larynx

0.00

0.0

1.5

—

11.17

—

Other sudden death, cause unknown

0.00

0.0

1.3

—

8.56

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

0.00

0.0

1.3

—

14.43

—

Sequelae of injuries involving multiple and unspecified body regions

0.00

0.0

1.3

—

13.17

—

Migraine, unspecified, drug-induced

0.00

0.0

1.2

—

9.00

—

Other and unspecified injuries of forearm

0.00

0.0

1.3

—

6.88

—

Wide developmental disorders

0.00

0.0

1.3

—

10.71

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

0.0

1.2

—

7.60

—

Other specified/unspecified disorders of tympanic membrane

0.00

0.0

1.2

—

13.50

—

Congenital malformations of breast

0.00

0.0

1.0

—

10.50

—

Melanoma in situ, other sites/unspecified

0.00

0.0

1.4

—

15.20

—

Adult-onset Still disease

0.00

0.0

1.2

—

7.17

—

Dementia due to Parkinsons disease, excluding more controls

1.00

0.00

1.3

1.4

9.13

13.67

u/l

—

Drug-induced obesity

0.00

0.0

1.3

—

8.43

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

0.0

1.3

—

14.33

—

Use of pergolide

0.00

0.0

1.5

—

8.17

—

Follicular adenocarcinoma of thyroid gland, including Hilmo

0.00

0.0

1.1

—

10.78

—

Neuroendocrine tumor and carcinoma of stomach

0.00

0.0

1.0

—

13.40

—

Non-seminoma of testis, including Hilmo

0.00

0.0

1.1

—

11.29

—

Calcium deposit in bursa

0.00

-0.00

0.0

1.2

—

10.67

—

Unspecified pneumoconiosis

0.00

-0.00

0.0

1.3

—

15.17

—

Bradycardia, unspecified, drug-induced

0.00

-0.00

0.0

1.3

—

13.86

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.2

—

9.00

—

Autism spe, excluding more controls

0.00

-0.00

0.0

1.3

—

9.43

—

Problems related to social environment

1.00

-0.00

1.3

1.2

7.17

15.02

u/l

—

Wide developmental disorders, excluding more controls

0.00

-0.00

0.0

1.3

—

12.89

—

Generalized pustular psoriasis

0.00

-0.00

0.0

1.5

—

7.75

—

Sequelae of inflammatory diseases of the central nervous system

0.00

-0.00

0.0

1.3

—

8.43

—

Disorders of muscle in diseases classified elsewhere

0.00

-0.00

0.0

1.3

—

7.00

—

Sequelae of burns, corrosions and frostbite

0.00

-0.00

0.0

1.3

—

12.71

—

Injury of blood vessels at neck level

0.00

-0.00

0.0

1.3

—

15.00

—

Acute inflammation of orbit

0.00

-0.00

0.0

1.3

—

9.43

—

Lens-induced iridocyclitis

0.00

-0.00

0.0

1.4

—

10.63

—

Other dermatomyositis

0.00

-0.00

0.0

1.0

—

17.20

—

Embolism and thrombosis of abdominal aorta

0.00

-0.00

0.0

1.0

—

17.40

—

Degenerative and vascular disorders of ear

0.00

-0.00

0.0

1.2

—

9.80

—

Injury of blood vessels at hip and thigh level

0.00

-0.00

0.0

1.2

—

18.40

—

Other and unspecified pemphigus

0.00

-0.00

0.0

1.4

—

7.88

—

Knuckle pads

0.00

-0.00

0.0

1.4

—

6.40

—

Enteritis due to Yersinia enterocolitica

0.00

-0.00

0.0

1.3

—

13.50

—

Juvenile Open Angle Glaucoma

0.00

-0.00

0.0

1.2

—

6.50

—

Autism

0.00

-0.00

0.0

1.2

—

8.83

—

Meningitis, viral

0.00

-0.00

0.0

1.2

—

10.20

—

Eccrine sweat disorders

0.00

-0.00

0.0

1.2

—

7.80

—

Multiple system atrophy (rare forms of Parkinsonism)

0.00

-0.00

0.0

1.2

—

9.20

—

Injury of blood vessels at forearm level

0.00

-0.00

0.0

1.7

—

7.83

—

Unspecified organic or symptomatic mental disorder

0.00

-0.00

0.0

1.3

—

7.67

—

Congenital malformations of eye, ear, face and neck

0.99

-0.00

1.1

1.2

10.63

11.15

u/l

—

Hereditary corneal dystrophies

0.93

-0.00

1.1

1.2

5.71

13.76

u/l

—

Progressive osseous muscle inflammation

0.00

-0.00

0.0

1.2

—

16.20

—

Injury of blood vessels at lower leg level

0.00

-0.00

0.0

1.1

—

11.13

—

Lesion of medial popliteal nerve

0.00

-0.00

0.0

1.5

—

7.67

—

Benign neoplasm: Skin of scalp and neck

0.93

-0.00

1.2

14.40

11.06

u/l

—

Fat embolism (traumatic)

0.00

-0.00

0.0

1.2

—

10.00

—

Autism spe

0.00

-0.00

0.0

1.2

—

8.83

—

Small kidney of unknown cause

0.00

-0.00

0.0

1.3

—

9.17

—

Traumatic spondylopathy

0.00

-0.00

0.0

1.5

—

6.33

—

Other disorders of binocular vision

0.00

-0.00

0.0

1.0

—

12.67

—

Congenital retinoschisis

0.00

-0.00

0.0

1.2

—

7.40

—

Qualitative platelet defects

0.00

-0.00

0.0

1.0

—

6.60

—

Vaginal lichen planus

0.00

-0.00

0.0

1.0

—

17.67

—

Superficial frostbite

0.00

-0.00

0.0

1.2

—

8.22

—

Toxic effect of contact with venomous animals

0.91

-0.00

1.2

10.83

10.97

u/l

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

1.2

—

6.20

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

0.00

-0.00

0.0

1.5

—

8.33

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

-0.00

0.0

1.1

—

7.43

—

Other congenital malformations of male genital organs

0.00

-0.00

0.0

1.0

—

8.60

—

Benign neoplasm: Mediastinum

0.00

-0.00

0.0

1.2

—

13.20

—

Congenital malformations of breast

0.00

-0.00

0.0

1.0

—

10.50

—

Idiopathic hypercalciuria

0.00

-0.00

0.0

1.3

—

5.67

—

Disorders of puberty, all

0.00

-0.00

0.0

1.0

—

15.40

—

Carcinoma in situ of vagina

0.00

-0.00

0.0

1.0

—

19.00

—

Other cestode infections

0.00

-0.00

0.0

1.2

—

15.17

—

Carcinoma in situ of oral cavity

0.00

-0.00

0.0

1.2

—

15.00

—

Benign neoplasm: Scrotum

0.00

-0.00

0.0

1.2

—

9.78

—

Phantom limb syndrome with pain

0.00

-0.00

0.0

1.3

—

6.14

—

Nonspecific lymphadenitis

0.96

-0.00

1.9

1.2

9.25

11.04

u/l

—

Mastocytosis

0.00

-0.00

0.0

1.5

—

13.83

—

Hypospadias

0.00

-0.00

0.0

1.4

—

10.60

—

Carcinoma in situ of lip, oral cavity and pharynx

0.00

-0.00

0.0

1.2

—

17.67

—

Maxillary retrognathism

0.00

-0.00

0.0

1.2

—

10.50

—

Carcinoma in situ of uteri, other/unspecified

0.00

-0.00

0.0

1.0

—

15.17

—

Benign neoplasm: Penis

0.00

-0.00

0.0

1.2

—

8.83

—

Esophageal diverticulum (pouch)

0.00

-0.00

0.0

1.4

—

11.00

—

Congenital retinoschisis

0.00

-0.00

0.0

1.2

—

7.40

—

Marfan's syndrome

0.00

-0.00

0.0

1.2

—

11.00

—

Spasmodic torticollis

1.02

-0.00

1.8

1.2

5.40

12.23

u/l

—

Follicular adenocarcinoma of thyroid gland

0.00

-0.00

0.0

1.1

—

10.78

—

Disorders of puberty

0.00

-0.00

0.0

1.0

—

8.60

—

Non-seminoma of testis

0.00

-0.00

0.0

1.2

—

14.00

—

Other specified/unspecified inflammatory spondylopathies

0.94

-0.00

1.0

1.3

6.67

11.08

u/l

—

Other specified/unspecified spondylopathies

1.01

-0.00

1.4

1.1

7.43

12.47

u/l

—

Adenocarcinoma of small intestine

0.00

-0.00

0.0

1.2

—

9.00

—

Other congenital malformations of male genital organs

0.00

-0.00

0.0

1.0

—

8.60

—

Other congenital malformations of kidney

0.00

-0.00

0.0

1.2

—

15.67

—

Absence of one kidney

0.00

-0.00

0.0

1.5

—

13.17

—

Use of rasagiline

0.88

-0.00

1.3

7.67

10.74

u/l

—

Abscess of tendon sheath

0.00

-0.00

0.0

1.4

—

8.29

—

Accidental poisoning by and exposure to other gases and vapours

0.00

-0.00

0.0

1.4

—

11.29

—

Traumatic subcutaneous emphysema

0.00

-0.00

0.0

1.4

—

8.60

—

Venous complications and haemorrhoids in the puerperium

0.00

-0.00

0.0

1.0

—

14.14

—

Traumatic amputation of ankle and foot

0.00

-0.00

0.0

1.2

—

15.20

—

Mandibular hypoplasia

0.00

-0.00

0.0

1.2

—

9.00

—

Contact with blunt object, undetermined intent

0.00

-0.00

0.0

1.2

—

8.80

—

Discharge from other and unspecified firearms

0.00

-0.00

0.0

1.0

—

7.80

—

Explosion of other materials

0.00

-0.00

0.0

1.6

—

7.20

—

Toxic encephalopathy

0.00

-0.00

0.0

1.2

—

14.33

—

Exposure to ignition or melting of other clothing and apparel

0.00

-0.00

0.0

1.4

—

8.60

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

-0.00

0.0

1.0

—

12.60

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

-0.00

0.0

1.4

—

11.56

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS